professor of ophthalmology director, center for retinal ... · professor of ophthalmology director,...

Updated: Nov. 14, 2016

CURRICULUM VITAE

Alessandro Iannaccone, MD, MS, FARVO

Professor of Ophthalmology Director, Center for Retinal Degenerations and Ophthalmic Genetic Diseases

CITIZENSHIP STATUS: Dual – Italian and American LANGUAGES: Fully fluent in English and Italian

Knowledge of medical and conversational Spanish and Portuguese Basic knowledge of French

EDUCATION: Pre-graduate miscellanea June – Aug. 81 Full-time Course, English Program for Foreign Students (EPFS), University of

Pennsylvania, Bennett Hall, 34th and Walnut Street, Philadelphia, PA 19104 (7th level) 1982 First Certificate of English, British Institute of Rome, Via Quattro Fontane 5, 00184

Rome, Italy July 1983 General Certificate of Education, Dante Alighieri High School, Via Ennio Quirino

Visconti 6, 00193 Rome, Italy Aug. – Oct. 83 Full-time Course, EPFS, University of Pennsylvania, Bennett Hall, 34th and Walnut

Street, Philadelphia, PA 19104 (College Skills level) Undergraduate N/A (College is not part of the standard Italian educational system: pre-clinical basic science

courses are included in the standard 6-year Medical School program) Graduate/Medical School Nov. 83 – Jul. 89 University of Rome “Sapienza”, School of Medicine (6-yr. program), P.le A. Moro 5, 00185

Rome, Italy (Registration Number: 03053907 aka C53907) July 20, 1989 M.D. degree with full marks and honors (110/110 e lode) Internship (rotations) May 89 – Nov. 89 Internal Medicine, III Clinica Medica (Prof. Bonomo)

Obstetrics and Gynecology, Clinica Ostetrica e Ginecologica (Prof. Pachì) Ophthalmology, Clinica Oculistica (Prof. Pannarale) University of Rome “Sapienza”, Policlinico Umberto I, Viale del Policlinico 1, Rome, Italy

Alessandro Iannaccone, MD, MS, FARVO – Curriculum Vitae – of 35

Residency Nov. 89 – Jul. 93 II School of Ophthalmology, Institute of Ophthalmology, University of Rome “Sapienza”,

Viale del Policlinico 1, 00185 Rome, Italy, Prof. M.R. Pannarale, Chairman (Registration Number: CT9509)

July 14, 1993 Ophthalmology diploma with full marks and honors (70/70 e lode)

Post-Graduate Training and Education Aug. 95 – Jul. 96 Retina Research Fellow, Scheie Eye Institute, University of Pennsylvania, 51 N. 39th

Street (Myrin Circle), Philadelphia, PA 19104 (Dr. S.G. Jacobson, Fellowship Program Director; Drs. A.M. Laties, J.E. Grunwald, E.N. Pugh, secondary mentors)

Nov. 96 – Aug. 98 Clinical and Research Fellow, Pediatric Retinal and Optic Nerve Diseases, Department

of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN (Dr. N.C. Kerr, Program Director)

April 29, 2000 ARVO Saturday Education Courses, Clinical Trials in Eye Research: A Hands-on

Workshop with the Experts, Drs. Maureen Maguire, Roy Beck, Frederick Ferris, Sheila West, Course Co-organizers

April 28, 2001 ARVO Saturday Education Courses, From Twin to Gene Function: An Overview of

Statistical Genetics. Dr. Donald Zack, Course Moderator Jan. 00 – May 03 M.S. degree, Master of Science in Epidemiology, University of Tennessee HSC,

College of Graduate Health Sciences, Memphis, TN (Dr. Stephen B. Kritchevsky, Program director and research advisor) – Thesis: Natural History of Visual Function Loss in Usher Syndrome Type 2 (defended: 12/11/02 – approved: 01/22/03)

April 30, 2005 ARVO Saturday Educational Courses, Nanotechnology and Nanomedicine:

Applications for Vision Research. Drs. Paul Sieving and Richard Fisher, National Eye Institute, Course Co-organizers

UNIVERSITY AND HOSPITAL APPOINTMENTS Sept. 97 – Dec. 05 Founding Director , Lions Visual Function Diagnostic Laboratory, Department of

Ophthalmology, Le Bonheur Children’s Medical Center, University of Tennessee HSC

(UTHSC), Memphis, TN Sept. 98 – June 04 Assistant Professor, non-tenure track, Department of Ophthalmology, UTHSC,

Memphis, TN July 04 – Dec. 2015 Associate Professor, non-tenure track, Department of Ophthalmology, UTHSC,

Memphis, TN Dec. 98 – Dec. 05 Director, Retinal Degeneration Referral Center, Department of Ophthalmology, Le

Bonheur Children’s Medical Center, UTHSC, Memphis, TN Jan. 99 – Dec. 2015 Member, Neuroscience Institute, Univ. of Tennessee HSC, Memphis, TN

Sept. 1999 – 2005 Member, Vascular Biology Program, UTHSC, Memphis, TN

Jan. 06 – Dec. 2015 Director, Retinal Degeneration & Ophthalmic Genetics Service, Department of

Ophthalmology, Hamilton Eye Institute, UTHSC, Memphis, TN Jan. 06 – Dec. 2015 Founding Director, Lions’ Visual Function Diagnostic Laboratory, Department of

Ophthalmology, Hamilton Eye Institute, UTHSC, Memphis, TN Sept. 1 – present Professor, non- tenure track, Dept. Ophthalmology, Duke Eye Center, Duke University

Medical Center, Durham, NC Sept. 1 – present Director, Center for Retinal Degenerations and Ophthalmic Genetic Diseases, Duke Eye

Center, Duke University Medical Center, Durham, NC

Hospital Privileges July 99 – Sept. 2015 Le Bonheur Children’s Medical Center, Memphis, TN, Consulting Staff Member

(affiliated with Univ. of Tennessee HSC, Memphis, TN) Aug. 99 – July 04 UT Bowld Hospital, University of Tennessee, Memphis, TN Active Staff Member

(affiliated with UTHSC, Memphis, TN) – privileges ended due to hospital closure)


Sept. 99 – Sept. 2015 Regional One Health (previously known as The Med Plex County Hospital), Memphis, TN, Active Staff Member until March 2009, Courtesy Staff Member thereafter (affiliated with UTHSC, Memphis, TN)

May 04 – Sept. 2015 Methodist University Hospital, Memphis, TN, Active Staff Member (affiliated with

UTHSC, Memphis, TN) Jan. 14 – Sept. 2015 Baptist Memorial Hospital – Metro (core Ophthalmology privileges, Baptist Eye Centre,

Baptist Women’s Hospital, Memphis, TN) Oct. 8 – present Duke University Hospital and affiliated institutions, Duke Eye Center, Duke University

Medical Center, Durham, NC OTHER PROFESSIONAL EXPERIENCE AND QUALIFICATIONS

Aug. 89 – Aug. 93 Voluntary Service, as intern and resident in ophthalmology, Center for Inherited

Degenerative Retinal Disorders, Institute of Ophthalmology, University La Sapienza, Rome, Italy (outpatient clinic and visual function & electrophysiology service)

July 91 – Aug. 91 Visiting M.D., Retina Service of the Scheie Eye Institute (Drs. S.L. Fine, J.E. Grunwald, A.J. Brucker) and at Oncology Service of the Wills Eye Hospital (Dr. J.A. Shields), Philadelphia, PA

1991 – 1994 Patient Advocacy Representative, Social Security Disability Applications Committee, Montesacro Local State Hospital (USL), Rome, Italy

1991 – 1995 Private Consultant, Patient Advocacy and Social Security Disability Applications, Province of Rome, Italy

Aug. 93 Visiting Ophthalmologist, Retinal Degeneration Center, Jules Stein Eye Institute, UCLA, CA (Dr. J.R. Heckenlively)

Sept. 93 – July 95 Voluntary Attending Ophthalmologist, Center for Inherited Degenerative Retinal Disorders, Institute of Ophthalmology, University La Sapienza, Rome, Italy (outpatient clinic and electrophysiology service)

Sept. 93 – Jan. 2014 Private Practice Consultant, Rome, Italy (RP and allied disorders, AMD, and medical retina, visual psychophysics and electro-diagnostics, retinal imaging, retinal laser photocoagulations, periocular and intravitreal injections)

Feb. – Apr. 94 Visiting Ophthalmologist, Instituto Brasiliense de Olhos, Brasília, DF, Brasíl (Dr. J.L. Pacini-Costa, director)

2007 – present Fellow, American Board of Disability Analysts (F.A.B.D.A.), Nashville, TN Nov. 09 – Dec. 11 Private Consultant, Eisai, Inc., Woodcliff Lake, NJ (provided to company expertise with

clinical trial protocol design and forms, with special reference to ERG testing methods, protocols, and interpretation of test outcomes during trials of drugs for neurodegenerative diseases) – Contact: Dr. Michael Everson, PhD, Associate Director, [email protected]

Apr. 10 – Aug. 13 Private Consultant, Apeliotus Technologies, Inc., Atlanta, GA (served as fundus photography expert reader for the company in the conduction of multi-center study of dark adaptation abnormalities in age-related macular degeneration) – Contact: John Edwards, CEO, [email protected]

Feb. 2014 – present Ophthalmic Clinical Consultant, Retinal Degenerations and Ophthalmic Genetics, MetaMedica, San Raffaele Hospital Group, Rome, Italy (RP and allied disorders, AMD, and medical retinal conditions, visual psychophysics and electro-diagnostics, retinal imaging, retinal laser photocoagulations, periocular and intravitreal injections) – Contact: Ms. Irina Balaj, COO, [email protected]

March 2015 – present KOL Consultant, ClearView Healthcare Partners, Newton, MA (provide expert opinion to

investors on treatment approaches being developed for retinal dystrophies and

degenerations) May 2015 – present KOL Consultant, GLG Group, San Francisco, CA (provide expert opinion to investors on

treatment approaches being developed for retinal dystrophies and degenerations)


Nov. 2015 – present KOL Consultant, Huron Consulting Group, New York, NY (provide expert opinion to investors on treatment approaches being developed for retinal dystrophies and degenerations)

Nov. 2015 – present KOL Consultant, ECRI Institute, Plymouth Meeting, PA (provide expert opinion to investors on retinal prosthetics)

Jan. – Aug. 2016 Unpaid Consultant, University of Tennessee Health Science Center, Dept. of Pharmaceutical Sciences, Memphis, TN (project on autoimmunity of macular degeneration) – Contact: Francesco Giorgianni, PhD, MBA, PI, [email protected]

Jan. 2016 – present Consultant, Ionis Pharmaceuticals, Carlsbad, CA (Clinical development and testing of therapies for retinal diseases, including various imaging, efficacy and safety endpoints assessments) – Contact: Michael L. McCaleb, PhD, [email protected]

March 2016 – present Consultant, Advance Medical, Inc., Westwood, MA (provide expert clinical review of

complex medical retinal cases, with special emphasis on retinal/macular dystrophies

and/or degenerations and other rare such disorders) – Contact: Ryan Zantua, MD,

Assistant Medical Director, [email protected] April and August 2016 Visiting Ophthalmologist, Center for Retinal and Macular Degeneration, Kellogg Eye

Center, University of Michigan, MI (Host: Dr. J.R. Heckenlively, Director; Far Vision

Foundation, sponsor) – Contact: [email protected] May – Sept. 2016 Consultant, EyeCRO, Oklahoma City, OK (provide clinical and translational research expertise

applied to the study and treatment of retinal degenerative diseases) – Contact: Rafal

Farjo, PhD, CEO, [email protected] HONORS AND AWARDS (includes select grants and contracts): Prizes, Awards and Other Recognitions

Feb. 1991 First prize, Italian Association for retinitis pigmentosa and low vision (AIRPI)

Dec. 1993 First prize, best poster presentation, 1st National Retinitis Pigmentosa Day, Rome, Italy.

Nov. 1997 Italian Society of Ophthalmology (SOI) Young Investigator Award

March 1998 ISER Travel Fellowship Award

December 1998 ISCEV Travel Grant

2001 Recipient, Certificate of Special Recognition for Outstanding Contribution, 2001

Memphis Challenge Program

2003 – 2007 Recipient, Career Development Award, Research to Prevent Blindness, Inc., New

York, NY

2007 America’s Top Physicians, Ophthalmology, Consumer’s Research Council of America

May 3, 2009 Recipient, 2009 ARVO/Alcon Early Career Clinician-Scientist Research Award

July 2012 Recipient, Physician-Scientist Award, Research to Prevent Blindness, Inc., New

York, NY

May 2014 Nomination, 2014 PhDA Postdoctoral Research Trainee Outstanding Mentor Academy

Award, UTSHC, Memphis, TN

Dec. 2015 Recipient, ARVO Silver Fellow status (Class of 2016)

Past Research Grants and Contracts (1997 – 2007)

1997 Instrumentation Grant Recipient (P.I.), Mid-South Lions’ Sight & Hearing Service,

Memphis, TN

1998 – 1999 Grant Recipient (P.I.), Knights Templar Eye Foundation, Chicago, IL

1998 – 2000 Grant Recipient (P.I.), Herbert & Mary Shainberg Neuroscience Research Program,

Memphis, TN

2000 Instrumentation Grant Recipient (P.I.), Industry Sponsor (macular pigment optical

densitometer)

1999 – 2001 Grant Recipient (P.I.), Fight For Sight Research Division, Prevent Blindness America,

Schaumburg, IL


1999 – 2001 Grant Recipient (P.I.), UT Medical Group Small Grant Program, Memphis, TN

2000 – 2004 Subcontractor, project #4: Clinical studies of Usher syndrome, Program Project Grant

DC01813-07, NIDCD, NIH, Bethesda, MD (PI: W.J. Kimberling, PhD)

2000 – 2001 Research Agreement (co-P.I.), Pharmaceutical Company

2000 – 2001 Grant Recipient (P.I.), Le Bonheur Research Grant Program, Memphis, TN

2000 – 2001 Grant Recipient (P.I.), Pharmaceutical Company

2001 – 2002 Co-Investigator, Prevention of Age-Related Macular Degeneration in the Women’s Health

Initiative Hormone Replacement Therapy Clinical Trial (Women ’s Health Initiative - Sight Examination Study), Wyeth-Ayerst (Ancillary Study to multi-center NIH-funded Women’s

Health Initiative (K.C. Johnson, M.D., M.P.H., UTHSC Preventive Medicine, Site P.I.)

2001 – 2003 Grant Recipient (P.I., A.J. Reiner, Ph.D., UTHSC Neuroscience, Co-P.I.), University of

Tennessee Vascular Biology Partnership Program

2001 – 2007 Grant Recipient (P.I.), K23 Patient-Oriented Mentored Research Career

Development Award, Grant EY000409, NEI, NIH, Bethesda, MD

2003 – 2004 Grant Recipient (P.I.), University of Tennessee Department of Ophthalmology Intramural

RPB Grant Program

2003 – 2005 Co-Investigator, International Retinal Research Foundation Grant, Birmingham, AL (P.I.:

M.M. Jablonski, UTHSC Ophthalmology, Ph.D.)

2003 – 2005 Grant Recipient (P.I.), Fight for Sight Foundn. Grant-in-Aid Program, New York, NY

2004 – 2006 Co-Investigator, American Health Assistance Foundation Macular Degeneration Research

Program Grant, New York, NY (P.I.: E.J. Johnson, PhD, Tufts University, Boston, MA)

2005 – 2006 Grant Recipient (P.I., M.M. Jablonski, Ph.D., Co-PI), Herbert and Mary Shainberg

Neuroscience Research Program, Memphis, TN

Other Honors Oct. 1, 2002 Session Moderator, Platform Session IIa, Mechanisms of Retinal Degeneration and Cell Death, X International Symposium on Retinal Degeneration, Bürgenstock,

Switzerland, Sept. 30 – Oct. 5, 2002

Oct. 1, 2002 Session Moderator, Platform Session IIb, Usher Syndrome: Models, Mechanisms and Therapy, X International Symposium on Retinal Degeneration, Bürgenstock,

Switzerland, Sept. 30 – Oct. 5, 2002

Sept. 11, 2003 Featured investigator, Channel 3 News Center for Discovery Researchers Collaborate to Find Cures of Eyesight Diseases, by Cheryl Kepes http://www.wreg.com/Global/story.asp?S=1438844&nav=CsqEHwak Dec. 21, 2003 Featured Investigator, Macular Degeneration Study, The Link (page 2) and press release

on UTMG web site http://www.utmedicalgroup.com/

Feb. 2004 Featured Investigator, Macular Degeneration Study, V.I.S.I.O.N.S. Newsletter, Vol. 9,

Issue 2, Senior Services’ Alliance for the Blind and Visually Impaired, Memphis, TN

March 7, 2005 Featured Investigator, Research to Prevent Blindness grant receipt announcement,

UTHSC News Center Press Release and Commercial Appeal, Memphis, TN Jan. 2006 Featured Investigator, Retinal Degeneration Care Relocates to Hamilton Eye Institute,

Service focuses on hereditary eye disease, clinical research, The Link (page 3) July 2006 Featured Investigator, Eye Institute to Participate in Macular Degeneration Trial, The

Record, UTHSC newsletter (page 7)

January 26, 2007 Meet-the-Docs Invited Panel Member, Foundation Fighting Blindness Study Section

Meeting, Orlando Omni Resort at ChampionsGate, Orlando, FL July 20-22, 2007 Invited Speaker, VISIONS 2007, Foundation Fighting Blindness National Conference,

Overland Park, KS

Jan. 2008 Featured Investigator, Staying Focused – Researchers are exploring new treatments for age-related macular degeneration, Memphis Magazine, URL:

http://www.memphisflyer.com/gyrobase/Content?oid=38868 Feb. 2008 Finalist, Associate Dean for Health Career Programs’ position, UTHSC College of

Graduate Health Sciences, Memphis, TN


Sept. 2008 Featured Investigator, Memphis VisionWalk Slated on October 18, The Link (page 2 –

honorary chair of event)

Oct. 14, 2008 Featured investigator, Channel 3 Live at Nine show, Retinal Degenerative Diseases

and VisionWalk, hosted by Mary Beth Conley & Alex Coleman

April 28, 2009 Featured investigator, Channel 3 Live at Nine show, Stargardt Disease and Low

Vision, hosted by Mary Beth Conley & Alex Coleman

May 7, 2009 Invited Moderator, ARVO 2009 Retinal Dystrophies II poster session, RE and BI

sections, Ft. Lauderdale, FL May 5, 2010 Invited Moderator, ARVO 2010 Retinitis Pigmentosa poster session, BI section, Ft.

Lauderdale, FL

2010 Contributor, The Retinal Atlas, L.A. Yannuzzi, Editor (provided illustrations and

synopsis of several cases with rare diseases for the atlas). Aug. 2014 Featured Investigator, Memphis Medical News, Memphis on the Mend, “FFB Driving

the Research to Fight Blindness”, by Pamela Harris, Marketing Publisher, p. 7, Aug.

2014 issue.

Aug. 2014 Featured Investigator, UTHSC Campus Faculty News http://news.uthsc.edu/dr-alessandro-iannaccone-invited-to-write-editorial-in-lancet-to-

comment-on-phase-1b-trial-of-hereditary-retinal-degeneration/

Aug. 2014 Featured Investigator, UTHSC Campus Faculty News http://news.uthsc.edu/dr-alessandro-iannaccone-featured-in-memphis-medical-news-

article-on-7th-memphis-visionwalk/

Sept. 2014 Featured Investigator, UTHSC Campus Faculty News http://news.uthsc.edu/dr- alessandro-iannaccone-invited-to-join-the-Scientific-Advisory-Board-of-the-

Choroideremia-Research-Foundation/ MEDICAL LICENSURE AND BOARD CERTIFICATION: Italian Board of Medical Examiners, Italian MD license

(issued: Jan. 1990; active, Ordine dei Medici Registration Number: 41475) ECFMG certificate, No. 0-562-600-7 (issued: May 5, 1997 – valid indefinitely)

Tennessee Board of Medical Examiners, Distinguished Faculty Medical License, No.

31230 Dec. 1998 – Feb. 2016 North Carolina Medical Board, Faculty Medical License, No. 2016-02702

Sept. 2016 – present (active) DEA license (all schedules): No. BI6334279

Pharmacy Board Researcher License, State of TN Dept of Health, No. 10960

(issued: Nov. 2014 – Dec. 2015) – for use of controlled substances/anesthetics with animals Board Certification: Eligible for certification by the American Board of Ophthalmology (ABO) under the new

Internationally Trained Ophthalmologist (ITO) track (as of Nov. 2014) with unrestricted MD license

SOCIETY MEMBERSHIPS: International Societies:

1992 – present Association for Research in Vision and Ophthalmology (ARVO)

1994 – present International Society for Clinical Electrophysiology of Vision (ISCEV)

1997 – present American Academy of Ophthalmology (AAO)

1997 – 2008 International Society for Eye Research (ISER)

1998 – 2003 American Association for the Advancement of Science (AAAS)

1999 – present International Society for Genetic Eye Disease and Retinoblastoma (ISGEDR)


National and Local Societies and Groups:

1990 – present Italian Society of Ophthalmology (SOI)

1990 – 2000 Italian Professional Association of Ophthalmologists (APIMO - merged with SOI

under the new acronym SOI-AMOI as of 2001)

1995 – 2001 Italian Society of Pediatric Ophthalmology (SIOP)

1997 – 2015 Memphis Eye Society, Honorary Member

2001 – present Downtown Memphis Lions Club Member

2003 – 2105 Tennessee Academy of Ophthalmology

2004 – present Research to Prevent Blindness Ophthalmological Associate

2007 – present Member-At-Large, Order of the Sons of Italy Association (OSIA)

2008 – present Fight For Sight Alumni Society TEACHING AND MENTORING EXPERIENCE: 1. June 97 – Aug. 97 Mentor, Courtney Carson, High School Student UT Summer Program. 2.

1998 – 2002 Lecturer, Module 4 of Ophthalmology, UT Medical Students 3. 1998 – Dec. 2003 Lecturer, Visual Electrophysiology and Psychophysics, Retinal Anatomy and Physiology,

Ophthalmic Genetics, Retinal Degenerations, UT Ophthalmology Residency Program 4. June 98 – Aug. 98Mentor, W. Brad Rouse, High School Student UT Summer Program. 5. June 99 – July 99Co-Mentor, Tara M. Feyen, High School Student UT Summer Program.

Co-Mentor, Richard McCluney, Pre-Med College Student (Wake Forest, NC)

6. May 00 – July 00Mentor, Richard McCluney, B.S., Pre-Medical School Student UTHSC, Memphis 7. May 00 – July 00Mentor, Ryan Robertson, High School Student, Memphis Challenge Program. 8. May 00 – July 00Mentor, Dewonia King, Christian Brothers University, UT Minority Opportunity Student

Program. 9. Aug. 00 – Dec. 00Mentor, Tim A. Parker, B.S., Southern College of Optometry student, Memphis, TN. 10. Nov. 01 – Jan. 02Mentor, Salvatore A. Tedesco, M.D., Visiting Ophthalmologist, University of Parma,

Department of Ophthalmology, Parma, Italy. 11. May 02 – July 02 Mentor, W. Andrew Todd, Tennessee Tech College Student, UT Summer College

Student Program

12. June 02 – Aug. 02 Mentor, Eduardo Maria Normando, B.S., Visiting Medical School Student, Campus

Biomedico University, Rome, Italy. 13. July 02 – June 03Mentor, Sara Saquib, M.D., Senior Research Assistant (Pakistan) 14. Jan. 03 – Sept. 04Thesis Committee Member, Songmei Meng, B.S. student, Masters of Science in

Epidemiology candidate, Univ. Tennessee College of Graduate Health Sciences, Memphis, TN.

15. May 03 – Aug. 03 Co-mentor, Lauren Mommsen (student at Arkansas State University, AR), Summer

College Student Program / McNair Program.

16. May 03 – Aug. 03 Co-mentor, Melissa Nelson (student at Central High School, Memphis, TN), Memphis

Challenge Student Program. 17. July 03 – June 04Mentor, W. Andrew Todd, B.S., Senior Research Assistant on ARMA Study. 18. Aug. 03 – Aug. 04Mentor, Basil Paulus, M.D., pre-residency intern and ophthalmology residency prospect. 19. Sept. 02 – Mar. 03Mentor, Salwa Ahmed, M.D., Senior Research Assistant on ARMA Study (Sudanese

ophthalmologist).

20. Jan. 04 – June 04 Mentor, Marco Mura, M.D., Research Scholar. 2nd

-year resident in Ophthalmology from

the University of Cagliari, Italy. 21. Feb. 04 – Dec. 15 Lecturer, Retinal Degenerations, Genetics & Epidemiology Series, Visual Electrophysiology

and Psychophysics, Retinal Anatomy and Physiology, Ophthalmic


Genetics, Retinal Degenerations, Basic Concepts of Biostatistics & Epidemiology, UT Ophthalmology Residency Program

22. April 04 – June 05Mentor, Jake P. Bostrom (M-3 Med School student, UTHSC, Memphis, TN). 23. June 04 – Dec. 06Mentor, Kevin Gallaher (Med School student, UTHSC, M-2 through M-4, Memphis, TN)

NIH Medical Student Research Fellowship Program, Stephen Tom, program coordinator. 24. June 04 – Aug. 04 Mentor, Tarsha L. Harris (senior student at Tougaloo College, Tougaloo, MS)

Summer College Student Program / McNair Program. 25. Jan. 06 – Dec. 15Mentor, Barbara J. Jennings, MA, OD (Research Scholar) 26. June 06 – Aug. 06Co-Mentor, Priya Sahu (Med School student, UTHSC, M-2) NIH Medical Student

Research Fellowship Program. 27. Jan. 07 – Dec. 07 Mentor, April M. Deaton-Cantrell, BS, COA – Winner of the 2007 Harold Stein Prize for

Best Scientific Paper from the Joint Commission of Allied Health Personnel in

Ophthalmology (JCAHPO) – sole winner, nationwide competition. 28. Jan. 07 – May 08Mentor, Jeremy T. Armstrong, Christian Brothers University. 29. Mar. 07 – Dec. 07Mentor, Lucas Romine (Med School student, UTHSC, M-3/4). 30. Oct. 07 – June 08Mentor, Lewis C. (“Cort”) Sommerville, MD, graduate of UTHSC Medical School. 31. Oct. 07 – Dec. 08Mentor, Monica Lynch (Med School student, UTHSC, M-3). 32. Jan. 08 – July 08Mentor, Denil Shekhat (Med School student, UTHSC, M-3). 33. Jan. 08 – Dec. 08Mentor, Ashley Laing (Med School student, UTHSC, M-3). 34. Jan. 08 – Jul. 2011 Mentor, Siva S. Radhakrishnan-Iyer, MD (resident, UTHSC Ophthalmology) – Winner of

best poster in clinical case series category and best poster overall of the Tennessee

Medical Association Residents and Fellows Meeting, Nashville, TN, April 11, 2009. 35. Jan. 09 – Sep. 2010 Mentor, Giovannella Carboni, MD (Research Scholar, UTHSC Ophthalmology) –

Awarded funding for a Masters & Back post-residency training program financed by the

regional government of Sardinia, Italy.

36. Jan. 09 – Sep. 2010 Mentor, Gina Forma, MD (Research Scholar, UTHSC Ophthalmology) Awarded funding

for a Masters & Back post-residency training program financed by the regional

government of Sardinia, Italy.

37. May 09 – Aug. 09 Mentor, Allyson L. Byrd (sophomore at University of Georgia, Athens, GA).

38. Oct. 09 – May 2010 Mentor, Maria Giulia Mutolo, MD (visiting MD, Department of Ophthalmology, S. Andrea

Hospital, Rome, Italy).

39. May – Aug. 2010 Mentor, Laura Mathews (St. Mary’s Episcopal High School student, Memphis, TN).

40. May 10 – May 12 Mentor, Aleksandr (Alex) Birg (Med School student, UTHSC, Memphis, TN) NIH Medical

Student Research Fellowship Program recipient, Stephen Tom, program coordinator.

Winner of 2011 NEI ARVO Travel Award.

41. May – Aug. 2011 Mentor, Allison Umfress (Duke University undergraduate student, Durham, NC), recipient

of the UTHSC Neuroscience Institute Undergraduate Merit Fellowship Award to work in

my lab during the summer.

42. May – Aug. 2011 Mentor, Lauryn Murphy (Christian Brothers University undergrad student, Memphis, TN).

43. July – Sept. 2011 Mentor, Sonali Dasgupta (Northwestern University undergraduate student, Chicago, IL).

44. Sept. 11 – June 13 Co-Mentor, Katie Mills, MD resident.

45. Mar. 12 – May 13 Co-Mentor, Kyle Cox (Med School student, UTHSC, Memphis, TN).

46. Mar. 12 – June 13 Co-Mentor, Ophthalmology Residents and Fellows –Drs. Calderwood, Kosko, Wilkin, and

and Huddleston (residents) and Dr. Aladdin Rashwani (fellow).

47. Jan. – Dec. 2013 Mentor, Albert H. Alhatem, MD (postdoctoral fellow) – Winner of 2014 ARVO Informa

Healthcare Travel Award.


48. Jan. 2013 – May 2015 Mentor, David D. New, PhD (postdoctoral fellow) –Winner of UTHSC Postdoc Association

Travel Award and 2014 ARVO C. Stephen and Frances B. Foster Foundation Travel

Award.

49. May – July 2013 Co-Mentor, Louise LaFlora (Med School student, Meharry University, Nashville, TN, with

Dr. Natalie Kerr, MD, FACS).

50. May 2013 – Aug. 2016 Mentor, Eric Sollenberger (Med School student, UTHSC, Memphis, TN) NIH Medical

Student Research Fellowship Program recipient.

51. May 2013 – Aug. 2016 Mentor, Rebecca S. Epstein, MD (Ophthalmology resident, UTHSC, Memphis, TN). AAO

poster received the highest grades within its subject area by the AAO Program Cmte.

52. Mar. – Aug. 2014 Co-Mentor, Justin Wilkin, MD (Ophthalmology senior resident, UTHSC, Memphis, TN,

with Dr. Natalie Kerr, MD, FACS).

53. Mar. – Aug. 2014 Mentor, Michael Hood, MD (Ophthalmology senior resident, UTHSC, Memphis, TN). 54. May 2014 – June 2015Mentor, T.J. Hollingsworth, PhD (postdoctoral fellow). 55. Aug. 2014 – Mar. 2015Co-Mentor, Joshua Barnett, PhD (M4 Med Student, with Dr. Natalie Kerr, MD, FACS,

accepted in Ophthalmology Residency at Vanderbilt) – Won Best Poster Award for

the Retina Section at the 2015 AAPOS Meeting. 56. Apr. 2015 – Mar. 2016Mentor, Rutviben Patel, BS (raising M4 Med Student, UTHSC, Memphis, TN). 57. Apr. 2015 – Mar. 2016Mentor, Cole Smith, BS (M4 Med Student, UTHSC, Memphis, TN). 58. June 2015 – presentMentor, Salar Rafieetary, BS (M4 Med Student, UTHSC, Memphis, TN). 59. Oct. 2016 – presentLecturer, Retinal Degenerations and Ophthalmic Genetics, Visual Electrophysiology and

Psychophysics, Retinal Anatomy and Physiology, Ophthalmic Genetics, Retinal Degenerations, Duke Eye Center Residency Program

INVITED LECTURES AND PRESENTATIONS:

1. July 27, 1993 Invited Speaker, Three-year experience in the treatment of retinitis pigmentosa with thymopentin. Dr. Eliot L. Berson, host, Berman-Gund Laboratory, Massachusetts Eye & Ear

Infirmary, Boston, MA

2. May 28, 1996 Invited Speaker, Visual function tests as an aid to the diagnosis and characterization of

retinal disorders. Dr. Richard S. Ruiz, host, Department of Ophthalmology, University of

Texas-Houston Health Science Center, Houston, TX

3. July 11, 1996 Invited Speaker, Visual function tests as an aid to diagnosis and characterization of retinal diseases. Dr. David G. Birch, host, Anderson Vision Research Center, Retina Foundation

of the Southwest, Dallas, TX

4. April 23, 1998 Invited Speaker, Update on hereditary retinal degenerations. Prof. Riccardo Neuschüler,

host, Division of Ophthalmology, Fatenebenefratelli Hospital, Isola Tiberina, Rome, Italy

5. Dec. 5, 1998 Invited Speaker, The Newly Established Retinal Degeneration Referral Center at the University of Tennessee. Louis Dawson, host, President, Foundation Fighting Blindness

Arkansas Affiliate Meeting, Jacksonville, AR

6. Feb. 4, 1999 Invited Speaker, The Newly Established Retinal Degeneration Referral Center at the University of Tennessee. Don Morris, Ed.D., host, Program Director. Alliance for the Blind

and Visually Impaired, Memphis, TN

7. Feb. 26, 1999 Invited Speaker, Genotype-phenotype correlations in macular degenerations. Prof. Luigi Scullica and Dr. Benedetto Falsini, hosts, Ophthalmic Education Course, Macular Degeneration: A Multidisciplinary Approach. Institute of Ophthalmology, Catholic University

of the Sacred Heart, Rome, Italy

8. March 19, 1999 Invited Speaker, Abnormalities of visual evoked potentials in children with neurofibromatosis type 1: preliminary findings. Dr. June Taylor, organizer, St. Jude

Children’s Research Hospital, Memphis, TN


9. March 26, 1999 Invited Speaker, The importance of Genotype-Phenotype Correlations in Hereditary

Retinal Diseases. Dr. Dianna Johnson, host, 1999 UT Memphis Vision Research

Symposium Molecular Biology/Molecular Genetics of the Visual System, University of

Tennessee, Coleman Building, South Auditorium, Memphis, TN 10. April 29, 1999 Invited Speaker, The Newly Established Retinal Degeneration Referral Center at the

University of Tennessee. Ms. Mildred Sessions, Host, Ascension Towers Retirement

Community, Memphis, TN 11. Sept. 19, 1999 Invited Speaker, Overview of Research at the Newly Established Retinal Degeneration

Referral Center at the University of Tennessee, Ms. Susan Freeze, host (lay audience)

Middle Tennessee Foundation Fighting Blindness Affiliate, Nashville, TN 12. Dec. 16, 1999 Invited Speaker, Allelic heterogeneity in autosomal dominant retinitis pigmentosa due to

different rhodopsin mutations: Clues from electroretinogram measurements Dr. William J. Kimberling, host, Center for Hereditary Communication Disorders,

Boys Town National Research Hospital, Omaha, NE 13. March 7, 2000 Invited Speaker, Genotype-phenotype correlations in autosomal dominant retinitis pigmentosa

due to rhodopsin mutations. Prof. Scullica and Neri, hosts, Ophthalmic Education Course,

Retinitis Pigmentosa: From Animal Models to Human Disease. Institute of Ophthalmology,

Catholic University of the Sacred Heart, Rome, Italy 14. June 2, 2001 Invited Speaker, X-linked Juvenile Retinoschisis. Elias Traboulsi, M.D., Jonathan Sears, M.D.,

and Joe Hollyfield, Ph.D., Co-directors, Ophthalmic Education Course, Pediatric and

Inherited Retinal diseases. Cole Eye Institute, The Cleveland Clinic, Cleveland, OH 15. Aug. 31, 2001 Invited Speaker, X- linked Juvenile Retinoschisis, Paul R. Lichter, M.D., host, W.K. Kellogg Eye

Center, Univ. of Michigan, Ann Arbor, MI 16. Feb. 19, 2002 Invited Speaker, Clinical and Functional Studies of X-linked Juvenile Retinoschisis

Paul A. Sieving, M.D., Ph.D., host, National Eye Institute, NIH, Bethesda, MD 17. April 15-16, 2002 Panel Speaker, Clinical Trials for Retinal Degenerative Diseases: Bridging the Efforts Across

Continents. Session II: Is Phenotype a Predictable and Useful Criteria for Patient

Selection? and Session III: Recruitment Resources: Mechanisms to Enroll the Appropriate

Patient Population, Prevalence and Databases. Josè-Alain Sahel, M.D., Ph.D., host, Palais

du Luxembourg, Paris, France 18. May 20, 2002 Invited Speaker, X-linked Retinoschisis: Clinical, Functional, and Differential Diagnostic

Aspects. Mark Sherwood, M.D., host, Dept. Ophthalmology, Univ. Florida, Gainesville, FL 19. Sept. 12, 2002 Invited Speaker, The Health ABC Age-Related Maculopathy Ancillary (ARMA) Study

Julie Mares-Perlman, Ph.D., host, Dept. of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI

20. Sept. 28, 2002 Invited Speaker, Present and Future of Genotypic and Phenotypic Studies in Hereditary

Retinal Degenerations, Claudio Macaluso, M.D., and Salvatore Tedesco, M.D., Co-

organizers, Ophthalmic Education Course, Hereditary Retinal Degenerations: From

Genetics to Clinical Manifestations. Dept. of Ophthalmology, University of Parma, Italy 21. Feb. 7/9, 2003 Invited Speaker, Usher syndrome. Broadcast radio interview on Eye on Vision, Vance

Durbin, host, WYPL Tennessee Public Library Radio (89.3 FM) 22. Feb. 21/23, 2003 Invited Speaker, Stargardt disease. Broadcast radio interview on Eye on Vision, Vance

Durbin, host, WYPL Tennessee Public Library Radio (89.3 FM) 23. April 3, 2003 Invited Speaker, The Health ABC Age-Related Maculopathy Ancillary (ARMA) Study,

Stephen B. Kritchevsky, Ph.D., host, UTHSC Dept. of Preventive Medicine, Health ABC Appreciation Day, Lindenwood Christian Church Auditorium, Memphis, TN

24. May 23/25, 2003 Invited Speaker, Best’s disease. Broadcast radio interview on Eye on Vision, Vance

Durbin, host, WYPL Tennessee Public Library Radio (89.3 FM) 25. July 4/6, 2003 Invited Speaker, Leber’s Congenital Amaurosis. Broadcast radio interview on Eye on

Vision, Vance Durbin, host, WYPL Tennessee Public Library Radio (89.3 FM)


26. Feb. 12, 2004 Invited Speaker, The Health ABC Age-Related Maculopathy Ancillary (ARMA) Study Council on Aging, Memphis, TN

27. April 20, 2004 Invited Speaker, The Health ABC Age-Related Maculopathy Ancillary (ARMA) Study

The Parkview Retirement Community, Memphis, TN (lay audience) 28. May 4, 2004 Invited Speaker, The Health ABC Age-Related Maculopathy Ancillary (ARMA) Study

St. Peter’s Manor Retirement Community, Memphis, TN (lay audience) 29. June 15, 2004 Invited Speaker, Epidemiology of Age-Related Vision Problems in the U.S. and in Tennessee,

Susanne Satterfield, M.D., host, UTHSC Dept. of Preventive Medicine, Health ABC

Appreciation Day, Lindenwood Christian Church Auditorium, Memphis, TN 30. Dec. 10, 2004 Invited Speaker, Macular Pigment Densitometry in the Elderly: A Promising Tool for Age-

Related Maculopathy Research , Distinguished Visiting Lecture, Sandra B. Blackwood,

Director, IRRF, and Lanning B. Kline, M.D., Chairman, UAB Dept. of Ophthalmology,

hosts, Callahan Eye Foundation Hospital, Smith Education Center, Birmingham, AL 31. Dec. 10, 2004 Invited Speaker, A Clinical, Diagnostic, and Genetic Overview of Hereditary Retinal Diseases,

Lanning B. Kline, M.D., Chairman, UAB Dept. of Ophthalmology, host, Callahan Eye

Foundation Hospital, John E. Meyer Library, Birmingham, AL 32. Dec. 15, 2004 Invited Speaker, RPGR Mutations Cause X-linked Pseudo-Usher Syndrome: A Clinical and

Immunohistochemical Study, J. Fielding Hejtmancik, M.D., Ph.D., host, National Eye

Institute, NIH, Cogan Library, Bethesda, MD 33. Jan. 7/21, 2006 Invited Speaker, Retinoschisis. Broadcast radio interview on Eye on Vision, Vance Durbin,

host, WYPL Tennessee Public Library Radio (89.3 FM) 34. April 8/29, 2006 Invited Speaker, Carotenoids and Age-Related Macular Degeneration. Radio interview on

Eye on Vision, Vance Durbin, host, WYPL Tenn. Public Library Radio (89.3 FM) 35. Oct. 5, 2006 Invited Speaker, Longitudinal Measurements of Visual Function in Usher Syndrome Type II,

First International Symposium on Usher Syndrome and Related Disorders, Dr. William

J. Kimberling and Dr. Claes Möller, co-organizers, Boys Town National Research

Hospital, Omaha, NE 36. April 7/21, 2007 Invited Speaker , The Foundation Fighting Blindness Mid -South Chapter. Broadcast radio

interview on Eye on Vision, V. Durbin, host, WYPL Tenn. Public Library Radio (89.3 FM) 37. May 19, 2007 Guest Speaker, Scientific Advances: A Cure is in Sight, UTHSC Hamilton Eye Institute,

Freeman Auditorium, J. David and Charlene Spiceland, Co-Presidents and hosts,

1st Foundation Fighting Blindness Mid-South Chapter of Memphis meeting,

Memphis, TN 38. July 20-21, 2007Invited Speaker, VISIONS2007, The Foundation Fighting Blindness, Kansas City, KC. 39. Dec. 4, 2007Invited Speaker, Clinical Research in Ophthalmology: Developing a Career As A Physician

Scientist Student Interest Group in Ophthalmology (SIGIO), Freeman Auditorium, UTHSC Hamilton Eye Institute, Memphis, TN

40. June 7, 2008 Guest Speaker, The Latest in Gene Therapy: Clinical Research Information You Won ’t Want

to Miss, UTHSC Hamilton Eye Institute, Freeman Auditorium, Foundation Fighting

Blindness Mid-South Chapter of Memphis meeting, Memphis, TN 41. Sept. 2, 2008 Invited Speaker, Multidisciplinary Approaches To Retinal Degenerations, UIC Department of

Ophthalmology & Visual Science, Gerald Fishman, MD, host, Chicago, IL 42. Oct. 4, 2008 Invited Speaker, Update on Gene Therapy for Leber’s Congenital Amaurosis, the Memphis

Vision Seminar and VisionWalk. Broadcast radio interview on Eye on Vision, V. Durbin,

host, WYPL Tenn. Public Library Radio (89.3 FM) 43. Oct. 11, 2008 Guest Speaker, 1. Genetics and Inheritance of Retinal Degenerative Diseases. 2. Retinitis

Pigmentosa and Other Inherited Diseases, Foundation Fighting Blindness’ Memphis

Vision Seminar, Fogelman Auditorium, University of Memphis, Memphis, TN


44. Jan. 13, 2009 Invited Speaker, Multidisciplinary Approaches To Retinal Degenerative Diseases, Wilmer Eye

Institute, Johns Hopkins University School of Medicine, Neil Bressler, MD and don Zack,

MD, hosts, Baltimore, MD 45. May 16, 2009 Guest Speaker, Scientific Update from the ARVO Meeting – Clinical Research Update,

UTHSC Hamilton Eye Institute, Freeman Auditorium, J. David and Charlene Spiceland,

Co-Presidents and hosts, Foundation Fighting Blindness Mid-South Chapter of Memphis meeting, Memphis, TN

46. Nov. 19, 2009 Invited Panelist, UTHSC Clinical and Translational Science Institute Genomics Think Tank Retreat. Fogelman Executive Center, Univ. Memphis, Memphis, TN

47. April 12, 2010 Invited Speaker, Multidisciplinary Approaches To The Study and Treatment of Retinal

Degenerative Diseases, Massachusetts Eye & Ear Infirmary, Harvard University, John

Lowenstein, host, Boston, MA 48. May 18, 2010 Guest Speaker, Update on current research topics in hereditary retinal diseases

UTHSC Hamilton Eye Institute, Freeman Auditorium, Foundation Fighting Blindness Mid-

South Chapter of Memphis meeting, Memphis, TN 49. Sept. 21, 2011 Invited Speaker, Update on treatment options for Leber’s congenital amaurosis and

retinitis pigmentosa. Broadcast radio interview on Eye on Vision, Vance Durbin,

host, WYPL Tenn. Public Library Radio (89.3 FM) 50. Oct. 11, 2011 Invited Speaker, Macular Pigment Optical Density: Findings in Aging and Age-Related

Maculopathy and Response to Supplementation. Fall 2011 Ocular Nutrition Society

(ONS) Nutrition Education Symposium 51. Dec. 12, 2011 Invited Speaker, Multidisciplinary Approaches To Retinal Degenerative Diseases. Jayne Weiss,

MD, Chair, host, Louisiana State University Eye Center, LSUHSC, New Orleans, LA 52. Dec. 30, 2014 Invited Speaker, Update on the role of inflammation and autoimmunity in age -related macular

degeneration. Broadcast radio interview on Eye on Vision, V. Durbin, host, WYPL Tenn.

Public Library Radio (89.3 FM) 53. Apr. 23, 2015 Invited Speaker, Understanding the Role of Autoimmunity in Age-Related Macular

Degeneration. David Gamm, MD, PhD, Director, McPherson Eye Research Institute,

host, Univ. Wisconsin, Madison, WI 54. Apr. 24, 2015 Invited Speaker, The Overlapping Worlds of Hereditary Retinal Degenerations and

Autoimmune Retinopathy: RP Phenocopies and Immune-Mediated Complications of

Retinal Dystrophies. Terri Young, MD, PhD, Chair, host, Dept. Ophthalmology,

Univ. Wisconsin, Madison, WI 55. April 28, 2015 Invited Speaker, Characterizing the role of autoimmunity in retinal degenerative diseases: Well

beyond simple disease biomarkers. Mechanistic commonalities between retinitis

pigmentosa, primary autoimmune retinopathies, and age-related macular degeneration. Jayne Weiss, MD, Chair, host, LSU Eye Center, LSUHSC, New Orleans, LA

56. May 11, 2015 Invited Speaker, Translational Studies of Inflammation and Autoimmunity in Age-Related

Macular Degeneration. Clivel Charlton, PhD, Chair, host, Dept. of Neuroscience and

Pharmacology, Meharry Medical College, Nashville, TN 57. May 14, 2015 Invited Speaker, The different facets of night blindness: Why phenotyping and genotyping both

matter. Douglas Lazzaro, MD, FACS, Chair, host, SUNY-Downstate, Department of

Ophthalmology, Brooklyn, NY 58. June 12, 2015 Invited Speaker, The Overlapping Worlds of Hereditary Retinal Degenerations and

Autoimmune Retinopathy. Nick Volpe, MD, Professor and Chair, Northwestern

University, Department of Ophthalmology & Visual Sciences, Chicago, IL 58. Aug. 10, 2015 Invited Speaker, Characterizing the role of autoimmunity in retinal degenerative diseases: Well

beyond simple disease biomarkers Todd Margolis, MD, PhD, Professor and Chairman,

host, Washington University, Dept. Ophthalmol. & Vis. Sci., St. Louis, MO 60. Dec. 1, 2015 Invited Speaker, Translational Studies on the Role of Autoimmunity in Age -Related Macular

Degeneration, Donald L. Budenz, MD, MPH, Professor and Chair, host, University of

North Carolina, Kittner Eye Center, Chapel Hill, NC


61. Jan. 5, 2016 Invited Speaker, The Overlapping Worlds of Hereditary Retinal Degenerations and

Autoimmune Retinopathy: RP Phenocopies and Immune-Mediated Complications of

Retinal Dystrophies. Grand Rounds presentation. Sonal Tuli, MD, Professor and

Chair, host. Dept. Ophthalmology, Univ. Florida, Gainesville, FL 62. Jan. 5, 2016 Invited Speaker, Translational Studies on the Role of Autoimmunity in Age-Related Macular

Degeneration. William Hauswirth, PhD, Professor and Director of Research, host. Dept.

Ophthalmology, Univ. Florida, Gainesville, FL 63. Jan. 13, 2016 Invited Speaker, Characterizing the role of autoimmunity in retinal degenerative diseases: Well

beyond simple disease biomarkers. Craig Greven, MD, Professor and Chair, Wake Forest

Dept. of Ophthalmology, Winston-Salem, NC 64. Feb. 2, 2016 Invited Speaker, Clinical and translational studies of retinal aging and degenerative

diseases – Relevance to interracial differences in health, pathology and response to treatment. Duane Smoot, MD, Professor, host. Meharry Translational Research Center (MeTRC), Meharry Medical College, Nashville, TN

COMMITTEES AND OFFICES HELD: Committees and Miscellanea 1998 - 1999 Member, 1999 Vision Research Symposium Organizing Committee, UT Vision

Research Center

1999 - 2002 Ad-Hoc Grant Reviewer, Foundation Fighting Blindness, Columbia, MD

June 7, 2002 Co-Honorary Chair (with Monica M. Jablonski, PhD), Give the Gifts X, 10th

Dinner and

Auction, Mid-South Lions Sight and Hearing Service, Ridgeway Inn, Memphis, TN

2004 - present Member, Healthy Memphis Common Table, Memphis, TN

2005 - present Ad-Hoc Grant Reviewer, Foundation Fighting Blindness, Columbia, MD

2006 Member, Macular Degeneration Grant Review Committee, Helen-Keller Foundation,

Birmingham, AL

Oct. 30-31, 2006 Member, NIH/NCCAM ZAT1 JH-18 Special Emphasis Panel Review Committee, Clinical

Research, National Center for Complementary and Alternative Medicine

Dec. 2006 - present Member, Clinical Research Review Committee, Foundation Fighting Blindness,

Columbia, MD (confirmed Committee member through 2020)

Jan. 25-26, 2007 Member, Foundation Fighting Blindness Study Section, Orlando Omni Resort at

ChampionsGate, Orlando, FL

Feb. 07 – Sep. 2010 Co-Founder and Chair of Education & Outreach Committee, Foundation Fighting

Blindness Mid-South Chapter of Memphis

April – Oct. 2008 Honorary Chair, Foundation Fighting Blindness 2008 1st

Memphis VisionWalk, Overton

Park, Memphis, TN, October 18, 2008

June – Oct. 2008 Site Organizer and Speaker, Foundation Fighting Blindness’ Memphis Vision Seminar

(Fogelman Center, University of Memphis, Memphis, TN, October 11, 2008)

Sep. 2008 - present Scientific Advisory Board Member, Foundation Fighting Blindness, Owings Mills,

MD (invited by Steve Rose, PhD, Chief Research Officer, confirmed through 2020)

Apr. - Oct. 2009 Fundraising Committee Member, 2009 2nd

Memphis VisionWalk, Foundation Fighting

Blindness, Overton Park, Memphis, TN, October 18, 2009

June – July 2009 Member, NIH ZRG1 CB-N (58) RC1 Grant Review Committee, Center for Scientific

Oct. 2009 – July 2015 Review Special Emphasis Panel Coordinator, Ophthalmology Game Coverage, Memphis Grizzlies, National Basketball

Association (NBA), Memphis, TN, Drew Graham, Head Athletic Trainer and Vice President

of Player Care

Mar. – April 2010 Ad-Hoc Grant Reviewer, University of Michigan Pilot Grant Program in Aging Research, University of Michigan's Claude Pepper Older Americans Independence Center, Nathan Shock Center of Excellence in Aging Research, and Michigan Institute for Clinical & Health

Research, Ann Arbor, MI


Mar. 2010 - present Editorial Board Member, Society for Clinical Ophthalmology

Apr. – Oct. 2010 Fundraising Committee Member, 2010 3rd

Memphis VisionWalk, Foundation Fighting Blindness, Overton Park, Memphis, TN, October 23, 2010

Sep. 2010 – Feb. 2011 Co-President and Interim Vice-President for Fundraising, Foundation Fighting Blindness Mid-South Chapter of Memphis

Nov. 2010 – Oct. 2011 Organizing Committee Member, 2011 4th


Feb. – Dec. 2011 Co-President, Foundation Fighting Blindness Mid-South Chapter of Memphis Aug. 2-3, 2011 Member, NEI R01/R13/R21 ZEY1 VSN (02) Grant Review Committee, National Eye

Institute Special Emphasis Panel Jan. 2012 Reviewer, Choroideremia Research Foundation, Springfield, MA

Nov. 2011 – Oct. 2012 Organizing Committee Member, 2012 5

th Memphis VisionWalk, Foundation Fighting

Blindness, Overton Park, Memphis, TN, October 20, 2012 Jan. 2012 – present President, Foundation Fighting Blindness Mid-South Chapter of Memphis

June 2012 – Oct. 13 Organizing and Planning Committee Member, Monaciano Symposium: A Strategic

Planning Retreat to Advance the Treatment of Hereditary Retinal Degeneration, Oct. 1-4, 2013, Monaciano, Tuscany, Italy (with Univ. of Michigan)

Nov. 2012 – Oct. 2013 Organizing Committee Member, 2013 6th


Nov. 2013 – Dec. 2014 Organizing Committee Member, 2014 7th

Memphis VisionWalk, Foundation Fighting Blindness, Patriot Lake at Shelby Farms, Memphis, TN, October 25, 2014

June 2014 - present Scientific Advisory Board Member, Choroideremia Research Foundation, Inc.,

Springfield, MA (invited as inaugural SAB member by Chris Moen, MD, President) Sept. 2014 - present Scientific Advisory Board Member, Blue Cone Monochromacy Families Foundation,

Jupiter, FL (invited as inaugural SAB member by Renata Sarno, PhD, President)

May 2015 - 2018 Appointed Member, Advocacy and Outreach Committee (AOC), Association for

Research in Vision and Ophthalmology (ARVO) – 3-year term March – April 2016 Member, NIH ZEY1 VSN 01, National Eye Institute Study Section

Journal Review Assignments Retina, Ophthalmic Genetics, British Journal of Ophthalmology, Documenta Ophthalmologica, Investigative

Ophthalmology and Visual Science (2002, Guest Editorial Board member), American Journal of Ophthalmology,

Eye , Molecular Vision, Journal of Medical Genetics, Comprehensive Ophthalmology Update, Hospital Physician and American Journal of Clinical Nutrition, Canadian Journal of Ophthalmology, Experimental Eye Research,

Archives of Ophthalmology/JAMA Ophthalmology, Current Eye Research, Retina Cases & Brief Reports, Cancers, Human Molecular Genetics, Human Gene Therapy, Translational Vision Science & Technology, Biology

Open Journal

RESEARCH AND OTHER EXTERNAL SUPPORT

Ongoing Research Support

1R01 EY022706-02, NEI/NIH Giorgianni (PI) 09/12 - 08/17

Autoimmunity and Age-Related Macular Degeneration

Role: PI until 12/31/15, Unpaid Consultant 1/16 – 8/16, Co-PI status activation pending

BrightFocus Foundation Macular Degeneration Giorgianni (PI) 7/16 - 6/18

Research Program, Clarksburg, MD In vitro and in vivo studies of CD5L/AIM as a possible key role player in drusen biogenesis Role: Co-Investigator, subcontract activation pending


Pending Support (includes recently submitted grants, grants awaiting resubmission, or established contacts with companies to

conduct clinical studies or trials as Site PI prior to 12/31/15, all start dates tentative pending relocation)

R01 EY026577, NEI/NIH Giorgianni (PI) 7/17 - 06/22 Translational investigations of CD5L/AIM in age-related macular degeneration

Role: Co-PI (MPI application)

FDA Office of Orphan Product Development Duncan (PI) 05/17 - 04/22 Rate of Progression in USH2A Related Retinal Degeneration (RUSH2A)

Role: Site PI (Multicenter Natural History Study)

Shire Human Genetic Therapies Iannaccone (Site PI) 1/17 - 12/21

Lexington, MA A Prospective, Multi-center, Longitudinal, Observational Natural History Study to Evaluate Disease Progression in

Subjects with Autosomal Dominant Retinitis Pigmentosa (adRP) with Misfolded Rod Opsin Mutations (SHP630-001)

Applied Genetic Technologies Corp. (AGTC) Iannaccone (Site PI) TBD

Alachua, FL

X-linked retinoschisis: A multi-center Phase I gene therapy trial (RS1-001)

Ionis Pharmaceuticals, Inc./Emmes Corp. Iannaccone (Site PI) 09/16 - 12/17 Retinitis Pigmentosa Natural History Study of Patients with the P23H Mutation

(Continuation of study I was already previously conducting at UTHSC)

Biotech company (TBD) Iannaccone (Site PI) TBD

Choroideremia: A multi-center Phase I gene therapy trial

Completed Research Projects (in chronological order, earliest to most recent, since 2001, highlighted in bold are the most significant ones)

K23 EY000409, NEI/NIH Iannaccone (PI) 12/01 - 12/07

Clinical epidemiology of retinal degenerations

International Retinal Research Iannaccone (PI) 04/02 - 12/07

Foundation, Inc., Birmingham, AL

Epidemiology of Carotenoids, Inflammation, and Genetic Markers in Age-Related Macular Degeneration

Research to Prevent Blindness, Inc. Iannaccone (PI) 01/03 - 12/07

New York, NY

Research to Prevent Blindness Career Development Award

Bhoeringer-Ingelheim (Ronald J. Pfeiffer, M.D. 04/07 - 05/09

(contract, multi-center Phase IV study) UTHSC Neurology, PI)

A Two-Year Open Label, Randomized, Parallel Group, Blinded Assessment Ophthalmologic Safety Study of Parkinson Disease Treatments (BIPI Trial 248.538)

Role: Subcontractor

Neurotech USA CNTF3 Trial Iannaccone (Site PI) 04/07 - 05/09

(Contract, multi-center Phase II/III study) A phase II/III study using a new experimental treatment for participants with retinitis pigmentosa using visual

acuity as the primary outcome


Neurotech USA CNTF4 Trial Iannaccone (Site PI) 04/07 - 05/10

(Contract, multi-center Phase II/III study) A phase II/III study using a new experimental treatment for participants with retinitis pigmentosa using visual

field sensitivity as the primary outcome

National Neurovision Research Institute Iannaccone (Site PI) 04/07 - 03/08

Foundation Fighting Blindness, Owing Mills, MD

Infrastructural Support for CNTF Trials

Hamilton Eye Institute Intramural Funding Iannaccone (PI) 04/07 - 03/08

Infrastructural Support for CNTF Trials

International Retinal Research Iannaccone (PI) 01/08 - 12/10

Foundation, Inc., Birmingham, AL

Autoimmune Biomarkers of Age-Related Macular Degeneration

Pfizer Adamolekun (Site PI) 01/08 - 12/10 Prospective Randomized, 12-Week Controlled Study of Visual Field Change in Subjects with Partial Seizures Receiving Active Treatment or Placebo Role: Subcontractor

Zeavision, St Louis, MO Iannaccone (PI) 01/09 - 12/10

Instrumentation Grant Recipient

R21 EY0118416, NEI/NIH Iannaccone (PI) 08/09 - 07/12

Auto-Antibodies as Serum Biomarkers for Age-Related Macular Degeneration

Intramural funding Kerr/Mills (PI) 01/12 - 12/12

Hamilton Eye Institute

Autoreactivity against Orbital Fat Tissue Antigens in Thyroid Eye Disease

Role: Co-Investigator

HHS-N-260-2005-00007-C Chaum (Site PI) 05/06 - 04/13

and N01-EY-5-0007, NEI/NIH

Age-Related Eye Disease Study 2 (AREDS2) Clinical Center Award

Role: 6/07 – 04/13, Site Co-Investigator (5/06 – 5/07, Site PI)

NEI/NIH, and Notal Vision, Ltd Chaum (Site PI) 06/10 - 04/13 Home Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the Foresee Home Device Role: Site Co-Investigator

Prana Biotechnology, Ltd. Ray Dorsey (PI) 6/12 – 6/13 Parkville, Australia Johns Hopkins

Reach2HD – A Huntington’s Disease Clinical Research Trial

Role: Co-Investigator (M. LeDoux, UTHSC Neurology, Site PI)

Research to Prevent Blindness Iannaccone (PI) 07/12 - 06/15

Physician Scientist Award

New York, NY

UT Pharmaceutical Sciences Giorgianni (PI) 09/13 - 08/14

Intramural Pilot Project UT Pharmaceutical Sciences

Identification of Autoimmunity Antigens in Age-Related Macular Degeneration Role: Co-Investigator


Foundation Fighting Blindness Iannaccone (Site PI) 11/11 - 12/15 Clinical Research Institute,

Columbia, MD

(formerly known as National Neurovision Research Institute) A Phase II Multiple Site, Randomized, Placebo-Controlled Trial of Oral Valproic Acid

for Retinitis Pigmentosa #H-13371 Dennis & Laura Gierhart Charitable Fund Iannaccone (PI) 04/09 - 12/15 Macular Pigment Optical Density: Functional Correlates Before and After Augmentation by An Open-Label, Short-

Term Pilot Dietary Supplementation with Zeaxanthin (ZEASTRESS-Pilot)

Ionis Pharmaceuticals, Inc./Emmes Corp. Iannaccone (site PI) 12/14-12/15 Retinitis Pigmentosa Natural History Study of Patients with the P23H Mutation of the Rhodopsin

Gene (RHONHS)


BIBLIOGRAPHY

Manuscripts Published on International Peer-Reviewed Journals

1. Vingolo EM, Rispoli E, Zicari D, Pannarale L, Iannaccone A, Fallucca F. Electrophysiologic monitoring

of diabetic retinopathy in pregnancy. Retina 1993; 13: 99-106. PMID 8337508

2. Rispoli E, Iannaccone A, Vingolo EM. Low-noise electroretinogram recording techniques in

retinitis pigmentosa. Doc. Ophthalmol. 1994; 88: 27-37. PMID 7743910

3. Vingolo EM, Steindl K, Forte R, Zompatori L, Iannaccone A, Sciarra A, Del Porto G, Pannarale

MR. Autosomal dominant simple microphthalmos. J. Med. Genet. 1994; 31: 721-725. PMID 7815444

4. Del Porto G, Vingolo EM, Steindl K, Forte R, Iannaccone A, Rispoli E, Pannarale MR. Clinical

heterogeneity of dominant optic atrophy: The contribution of visual function investigations to diagnosis.

Graefe’s Arch. Clin. Exp. Ophthalmol. 1994; 232: 717-727. PMID 7890185 5. Iannaccone A, Rispoli E, Vingolo EM, Onori P, Steindl K, Rispoli D, Pannarale MR. Correlation between

Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa. Doc. Ophthalmol.

1995; 90: 129-142. PMID 7497885 6. Iannaccone A, Vingolo EM, Rispoli E, De Propris G, Tanzilli P, Pannarale MR. Electroretinographic

alterations in the Laurence-Moon-Bardet-Biedl phenotype. Acta Ophthalmol. Scand. 1996; 74: 8-13.

PMID 8989489 7. Pannarale MR, Grammatico B, Iannaccone A, Forte R, De Bernardo C, Flagiello L, Vingolo EM, Del Porto G.

Autosomal dominant retinitis pigmentosa associated with an Arg-135-Trp point mutation of the rhodopsin

gene: Clinical features and longitudinal observations. Ophthalmology 1996; 103: 1443-1452. PMID 8841304 8. Iannaccone A, De Propris G, Roncati S, Rispoli E, Del Porto G, Pannarale MR. The ocular phenotype of

the Bardet-Biedl syndrome. Comparison to non-syndromic retinitis pigmentosa. Ophthalmic Genetics 1997;

18: 13-26. PMID 9134546 9. Letizia C, Iannaccone A, Cerci S, Santi G, Cilli M, Pannarale MR, Scavo D. Circulating endothelin-1 in non-

insulin-dependent diabetic patients with retinopathy. Horm. Metab. Res. 1997; 29: 247-251. PMID 9228211 10. Iannaccone A, Letizia C, Pazzaglia S, Vingolo EM, Clemente G, Pannarale MR. Plasma endothelin-1

concentrations in patients with retinal vein occlusions. Br. J. Ophthalmol. 1998; 82; 498-503. PMID 9713055 11. Iannaccone A. Clinical and functional features of patients with dominant optic atrophy. [letter].

Arch. Ophthalmol. 1999; 117: 287-288. PMID 10037588

12. Iannaccone A, Letizia C. Plasma endothelin-1 concentrations in patients with retinal vein occlusions. Br. J.

Ophthalmol. 1999; 83(1): 127-128 [letter].

13. Grunwald JE, Iannaccone A, DuPont J. Effect of 5-isosorbide mononitrate on the human optic nerve

and choroidal circulations. Br. J. Ophthalmol. 1999; 83: 162-167. PMID 10396191

14. Iannaccone A, DuPont J, Grunwald JE. Human retinal hemodynamics following oral administration of

5-isosorbide mononitrate. Curr. Eye Res. 2000; 20: 205-210. PMID 10694896

15. Jacobson SG, Cideciyan AV, Iannaccone A, Weleber RG, Fishman GA, Maguire AM, Affatigato LM,

Bennett J, Pierce EA, Danciger M, Farber DB, Stone EM. Disease expression of RP1 mutations causing

retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 2000; 41: 1898-1908. PMID 10845615 16. Jablonski MM, Iannaccone A. Targeted disruption of Müller cell metabolism induces

photoreceptor dysmorphogenesis. Glia 2000; 32: 192-204. PMID 11008218

17. Jablonski MM, Tombran-Tink J, Mrazek DA, Iannaccone A. Pigment epithelium-derived factor supports

normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium

removal. J. Neurosci. 2000; 20: 7149-7157. PMID 11007870 18. Jablonski MM, Iannaccone A. Lactose supports Müller cell protein expression patterns in the absence of

the retinal pigment epithelium. Mol. Vis. 2001; 7: 27-35. PMID 11239243

19. Nishimura DY, Searby CC, Carmi R, Elbedour K, Van Maldergem L, Fulton AB, Lam B, Powell B,

Swiderski RE, Bugge KE, Haider NB, Kwitek-Black AE, Ying L, Duhl DM, Gorman SM, Heon E,

Iannaccone A, Jacobson SG, Stone EM, Sheffield VC. Positional cloning of a novel gene on chromosome

16q causing Bardet-Biedl syndrome (BBS2). Hum. Mol. Genet. 2001; 10: 865-874. PMID 11285252 20. Jablonski MM, Graney MJ, Kritchevsky SB, Iannaccone A. Reliability assessment of a rod photoreceptor

outer segment grading system. Exp. Eye Res. 2001; 72: 573-579. PMID 11311049


21. Mykytyn K, Braun T, Carmi R, Haider NB, Searby CC, Shastri M, Beck G, Wright AF, Iannaccone A, Elbedour

E, Riise R, Baldi A, Raas-Rothschild A, Gorman SW, Duhl DM, Jacobson SG, Casavant T, Stone EM,

Sheffield VC. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat. Genet. 2001; 28: 188-191. PMID 11381270

22. Jablonski MM, Tomban-Tink J, Mrazek DA, Iannaccone A. Pigment epithelium-derived factor supports

normal Müller cell development and glutamine synthetase expression after removal of the retinal pigment epithelium. Glia 2001; 35:14–25. PMID 11424188

23. Iannaccone A. Genotype-phenotype correlations and differential diagnosis in autosomal dominant

macular disease. Doc. Ophthalmol. 2001; 102: 197-236. PMID 11556486

24. Wohabrebbi A, Umstot ES, Iannaccone A, Desiderio DM, Jablonski MM. Downregulation of a novel photoreceptor

protein correlates with improper outer segment assembly. J. Neurosci. Res. 2002; 67: 298-308.

PMID 11813234 25. Lyubarsky A, Lem J, Chen J, Falsini B, Iannaccone A, Pugh EN. Functionally rodless mice: transgenic

models for the investigation of cone function in retinal disease and therapy. Vision Res. 2002; 42: 401-415.

PMID 11853756 26. Breuer DK, Yashar BM, Filipova E, Hiriyanna S, Lyons R, Asaye B, Acar C, Vervoort R, Wright AF, Musarella

M, Wheeler P, MacDonald I, Iannaccone A, Birch D, Hoffman DR, Fishman GA, Heckenlively JR, Jacobson

SG, Sieving PA, Swaroop A. A comprehensive analysis of RPGR and RP2 genes in 233 families with X-

linked retinitis pigmentosa. Am. J. Hum. Genet. 2002; 70: 1545-1554. PMID 11992260 27. Iannaccone A, McCluney RA, Brewer VR, Spiegel PH, Kerr NC, Taylor JS, Pivnick EK. Visual evoked

potential abnormalities in children with neurofibromatosis type 1. Doc. Ophthalmol. 2002; 105: 63-81.

PMID 12152804 28. Iannaccone A, McIntosh N, Ciccarelli ML, Baldi A, Mutolo PA, Tedesco SA, Engle EC. Familial

unilateral Brown syndrome. Ophthalmic Genet. 2002; 23: 175-184. PMID 12324876

29. Koenekoop RK, Fishman GA, Iannaccone A, Ciccarelli ML, Ezzeldin H, Baldi A, Sunness JS, Lotery A,

Jablonski MM, Pittler SJ, Maumenee I. Electroretinographic and psychophysical abnormalities in parents

of Leber Congenital Amaurosis patients. Arch. Ophthalmol. 2002; 120: 1325-1330. PMID 12365911 30. Mykytyn K, Nishimura DY, Searby CC, Beck G, Bugge K, Streb LM, Cornier A, Cox GF, Fulton AB, Carmi R,

Luleci G, Iannaccone A, Jacobson SG, Weleber RG, Wright AF, Riise R, Hennekam RCM, Biesecker LG,

Stone EM, Sheffield VC. Evaluation of complex inheritance involving the most common Bardet-Biedl

syndrome locus (BBS1). Am. J. Hum. Genet. 2003; 72: 429-437. PMID 12524598 31. Acar C, Mears AJ, Yashar BM, Maheshwary AS, Andreasson S, Baldi A, Sieving PA, Iannaccone A,

Musarella MA, Jacobson SG, Swaroop A. Mutation screening of patients with Leber Congenital Amaurosis or

the Enhanced S-Cone Syndrome reveals a lack of sequence variations in the NRL gene. Mol. Vis. 2003; 9:

14-17. PMID 12552256 32. Iannaccone A, Wang XF, Kuo SF, Baldi A, Cosgrove D, Morton CC, Swaroop A, Jablonski MM. X-linked

pseudo-Usher syndrome due to mutations in the RPGR gene: A newly recognized clinical entity [e-

publication] J. Med. Genet. 2003 http://jmg.bmjjournals.com/cgi/eletters/40/8/609#29. 33. Iannaccone A, Breuer DK, Wang XF, Kuo SF, Normando EM, Filippova E, Baldi A, Hiriyanna S, MacDonald

CB, Baldi F, Cosgrove D, Morton CC, Swaroop A, Jablonski MM. Clinical and immuno-histochemical

evidence for an X-linked retinitis pigmentosa syndrome with recurrent infections and hearing loss in

association with an RPGR mutation. J. Med. Genet. 2003; 40:e118. PMID 14627685 34. Iannaccone A. Usher syndrome: Correlation between visual field size and maximal ERG response b-

wave amplitude. In: La Vail MM, Hollyfield JG, Anderson RE, eds, Retinal Degenerations: Mechanisms

and Experimental Therapy. Adv. Exp. Med. Biol. 2003; 533: 123-31. PMID 15180256 35. Wang XF, Iannaccone A, Jablonski MM. Permissive glycan support of photoreceptor outer segment

assembly occurs via a non-metabolic mechanism. Mol. Vis. 2003; 9: 701-709. PMID 14685163

36. Iannaccone A, Kritchevsky SB, Ciccarelli ML, Tedesco SA, Macaluso C, Kimberling WJ, Somes G. Kinetics of

Goldmann visual field loss in Usher syndrome type II. Invest. Ophthalmol. Vis. Sci. 2004; 45: 784-792. PMID

14985291 37. Iannaccone A, Wang XF, Kuo SF, Baldi A, Cosgrove D, Morton CC, Swaroop A, Jablonski MM. Increasing

evidence for syndromic phenotypes associated with RPGR mutations. Am. J. Ophthalmol. 2004; 137: 785-786.

PMID 15059739


38. Gruber M, Chappell R, Millen A, LaRowe T, Moeller SM, Iannaccone A, Kritchevsky SB, Mares J.

Correlates of serum lutein + zeaxanthin: Findings from the Third National Health and Nutrition Examination

Survey. J. Nutr. 2004; 134: 2387-2394. PMID 15333733 39. Iannaccone A, Sarkisian SR, Jr, Kerr NC, Morris WR. The genetics of glaucoma, cataracts and

corneal dystrophies. Comp. Ophthalmol. Update 2004; 5: 307-326. (invited review)

40. Iannaccone A, Mykytyn K, Persico AM, Baldi A, Jablonski MM, Sheffield VC. Clinical evidence of

decreased olfaction in Bardet-Biedl syndrome caused by a deletion in the BBS4 gene. Am. J. Med. Genet.

A. 2005; 132A(4): 343-346. (online-only supplemental material is available at: http://www.interscience.wiley.com/jpages/1552-4825/suppmat/index.html) PMID 15654695

41. Iannaccone A. The Genetics of Hereditary Retinopathies and Optic Neuropathies. Comp. Ophthalmol.

Update 2005; 6: 39-62 (invited review)

42. Wang XF, Iannaccone A, Jablonski MM. Contribution of Müller cells toward the regulation of

photoreceptor assembly. Neuron Glia Biology 2005; 1: 1-6. PMID 16528406

43. Iannaccone, A, Mura, M, Dyka, FM, Ciccarelli, ML, Yashar, BM, Ayyagari, R, Jablonski, MM, Molday, RS. An

unusual X-linked retinoschisis phenotype and biochemical characterization of the W112C RS1 mutation.

Vision Res. 2006; 46: 3845-52. (suppl. material online). PMID 16884758 44. Vasireddy V, Jablonski MM, Mandal MNA, Raz-Prag D, Wang XF, Lesli N, Iannaccone A, Musch DC,

Bush RA, Salem Jr N, Sieving PA, Ayyagari R. Elovl4 5bp-deletion knock-in mice develop progressive

photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2006; 47: 4558-68. PMID 17003453 45. Iannaccone A, Man D, Waseem N, Jennings BJ, Gallaher K, Reese E, Bhattacharya SS, Klein-

Seetharaman J. Retinitis Pigmentosa: Phenotypic Variability and Molecular Structural Effects Associated

with Rhodopsin Mutations. Vision Res. 2006; 46: 4556-67 (suppl. material online). PMID 17014888 46. Jablonski MM,* Iannaccone A,* Reynolds DH, Gallaher P, Allen S, Wang XF, Reiner AJ. Age-related

decline of VIP-positive vasoactive neural networks in the submacular choroid. Invest. Ophthalmol. Vis. Sci.

2007; 48: 479-485. – *equal contribution. PMID 17251439 47. Iannaccone A, Mura M, Gallaher KT, Johnson EJ, Todd WA, Kenyon E, Harris TL, Harris T, Satterfield S,

Johnson KC, Kritchevsky SB for the Health ABC Study. Macular pigment optical density in the elderly.

Methodological issues and findings in a large biracial Mid-South population sample. Invest. Ophthalmol. Vis. Sci. 2007; 48(4): 1458-65 (suppl. material online). PMID 17389471

48. Gallaher KT, Mura M, Todd WA, Harris TL, Kenyon E, Harris T, Johnson KC, Satterfield S, Kritchevsky SB,

Iannaccone A for the Health ABC Study. Macular pigment optical density in the elderly. Test-retest variability and

effect of optical blur in pseudophakic subjects. Vision Res. 2007; 47(9): 1253-59. PMID 17376502 49. Iannaccone A, Tedesco SA, Gallaher KT, Yamamoto H, Charles S, Dryja TP. Fundus albipunctatus in a 6-

year old girl due to compound heterozygous mutations in the RDH5 gene. Doc. Ophthalmol. 2007; 115:

111-16. PMID 17476461 50. Mura M, Sereda C, Jablonski MM, MacDonald IM, Iannaccone A. Clinical and functional findings in

choroideremia due to complete deletion of the CHM gene. Arch. Ophthalmol. 2007; 125: 1107-13.

PMID 17698759 51. Iannaccone A, Gallaher KT, Buchholz J, Jennings BJ, Sidjanin DJ. Identification of two novel mutations

in families with X-linked ocular albinism. Mol. Vis. 2007; 13:1856-61. PMID: 17960122

52. Iannaccone A, Othman MI, Cantrell AD, Jennings BJ, Branham K, Swaroop A. Retinal phenotype of an X-

linked pseudo-Usher syndrome in association with the G173R mutation in the RPGR gene. Adv. Exp.

Med. Biol. 2008; 613: 221-227. PMID 18188948 53. Miyake N, Chilton J, Psatha M, Cheng L, Andrews C, Chan W-M, Law K, Crosier M, Lindsay S, Cheung M,

Allen J, Gutowski NJ, Ellard S, Young E, Iannaccone A, Appukuttan B, Stout JT, Christiansen S, Ciccarelli

ML, Baldi A, Campioni M, Zenteno JC, Mariani LE, Sahin M, Guthrie S, Engle EC. Human CHN1

mutations hyperactivate a2-chimaerin and cause Duane’s Retraction Syndrome. Science 2008; 321(5890): 839-43 (suppl. material online). PMID 18653847

54. Iannaccone A, Fung KH, Eyestone ME, Stone EM. Treatment of Adult-Onset Acute Macular Retinoschisis

in Enhanced-S Cone Syndrome with Oral Acetazolamide. Am. J. Ophthalmol. 2009; 147(2): 307-312.e2

(suppl. material online). PMID 18835469 55. Philp AR, Jin M, Li S, Schindler EI, Iannaccone A, Lam BL, Weleber RG, Fishman GA, Jacobson SG, Mullins

R, Travis GH, Stone EM. Predicting the Pathogenicity of RPE65 Mutations. Human Mutation 2009;

30(8):1183-8. PMID 19431183


56. Iannaccone A*, Kerr NC*, Kinnick TR, Calzada JI, Stone EM. Autosomal Recessive Best's Vitelliform Macular

Dystrophy: Report of a Family and Management of Early-Onset Neovascular Complications. Arch.

Ophthalmol. 2011; 129(2): 211-7 – *Equal contribution. PMID 21320969 57. Sanders JL, Iannaccone A, Boudreau R, Conley YP, Opresko PL, Hsueh W-C, Cummings SR, Cawthon RM,

Harris TB, Nalls MA, Kritchevsky SB, Newman AB, for the Health ABC Study. The Association of Cataract

With Leukocyte Telomere Length in Older Adults: Defining a New Marker of Aging. J Gerontol A Biol Sci Med Sci. 2011; 66(6): 639-45. PMID 21382885

58. Spencer KL, Olson LM, Schnetz-Boutaud N, Scott WK, Gallins P, Agarwal A, Pericak-Vance MA, Iannaccone A,

Kritchevsky SB, Garcia M, Kenyon E, Nalls M, Newman AB, Haines JL. Using Genetic Variation and Environmental

Risk Factor Data to Identify Individuals at High Risk for Age-Related Macular Degeneration. PLoS ONE 2011; 6(3):

e17784. doi:10.1371/journal.pone.0017784 (suppl. material online). PMID 21455292 59. Adamus G, Brown L, Schiffman J, Iannaccone A. Diversity in autoimmunity against retinal, neuronal and

axonal antigens in acquired neuro-retinopathy. J. Ophthal. Inflamm. Infect. 2011; 1(3): 111-21. Epub 2011

Jul 10. PMID 21744285 60. Jacobson SG, Cideciyan AV, Ratnakaram R, Heon E, Schwartz SB, Roman AJ, Peden MC, Aleman TS, Boye

SL, Sumaroka A, Conlon TJ, Calcedo R, Pang J-J, Erger KE, Olivares MB, Mullins CL, Swider M, Kaushal S, Feuer WJ, Iannaccone A, Fishman GA, Stone EM, Byrne BJ, Hauswirth WW. Gene Therapy for Leber

Congenital Amaurosis caused by RPE65 mutations: Safety and Efficacy in Fifteen Children and Adults Followed up to Three Years. Arch Ophthalmol 2012; 130(1): 9-24 (suppl. material online). PMID 21911650

61. Iannaccone A, Neeli I, Krishnamurthy P, Lenchik N, Wan H, Gerling IC, Desiderio DM, Radic MZ.

Autoimmunity in Age-Related Macular Degeneration: A Possible Role Player in Disease Development

and Progression. Adv. Exp. Med. Biol. 2012; 723:11-6. PMID 22183309

62. De Falco M, Manente L, Lucariello A, Baldi G, Fiore P, Laforgia V, Baldi A, Iannaccone A, De Luca A.

Localization and distribution of wolframin in human tissues. Front. Biosci. (Elite Ed) 2012; E4 (5): 1986-98. PMID 22202014

63. Carboni G, Forma G, Bond AD, Adamus G, Iannaccone A. Bilateral paraneoplastic optic neuropathy in

association with prostate cancer and unilateral central retinal artery occlusion: A differential diagnostic

challenge in a patient with unexplained visual loss. Doc. Ophthalmol. 2012; 125(1): 63-70. PMID 22569848 64. Burke T, Fishman GA, Zernant J, Schubert C, Tsang SH, Smith RT, Ayyagari R, Koenekoop RK, Umfress A,

Ciccarelli ML, Baldi A, Iannaccone A, Cremers FP, Klaver CCV, Allikmets R. Retinal phenotypes in patients

homozygous for the G1961E mutation in the ABCA4 gene. Invest. Ophthalmol. Vis. Sci. 2012; 53(8): 4458-67. PMID: 22661473

65. Cox K, Kerr NC, Kedrov M, Nishimura D, Jennings BJ, Stone EM, Sheffield VC, Iannaccone A. Phenotypic

Expression of Bardet-Biedl Syndrome in Patients Homozygous for the Common M390R Mutation in the

BBS1 Gene. Vision Res. 2012; 75(12): 77-87. PMID 22940089 66. Branham K, Othman M, Brumm MV, Karoukis AJ, Atmaca-Sonmez P, Yashar BM, Schwartz SB, Stover NB,

Trzupek K, Wheaton D, Jennings BJ, Ciccarelli ML, Jayasundera KT, Lewis, RA, Birch D, Bennett J, Sieving PA,

Andreasson S, Duncan JL, Fishman GA, Iannaccone A, Weleber RG, Jacobson SG, Heckenlively JR, Swaroop A.

Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease.

Invest. Ophthalmol. Visc. Sci. 2012; 53(13): 8232-37 PMID: 23150612 67. AREDS2 Research Group*, Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W,

Sperduto R, Ferris FL. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline

characteristics (AREDS2 report number 1). Ophthalmology 2012; 119(11): 2282-9. (*member, see appendix

to paper) PMID: 22840421 68. Age-Related Eye Disease Study 2 Research Group*. Lutein + zeaxanthin and omega-3 fatty acids for

age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical

trial. JAMA 2013; 309(19): 2005-15. Erratum in: JAMA 2013; 310(2): 208. (*member, see appendix to paper) PMID: 23644932

69. Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, Sangiovanni JP, Ferris FL 3rd; AREDS2

Study Group*. Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the

Age-Related Eye Disease Study 2 (AREDS2 Report Number 2). Invest. Ophthalmol. Vis. Sci. 2013; 54(7):

4548-4554 (*member, see appendix to paper). PMID: 23620429 70. Birch DG, Weleber RG, Duncan JL, Jaffe GJ, Tao W; Ciliary Neurotrophic Factor Retinitis Pigmentosa

Study Groups*. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular


implants for retinitis pigmentosa. Am. J. Ophthalmol. 2013; 156(2): 283-292.e1. (*member, see appendix to paper). PMID: 23668681

71. Wang X, Wang H, Sun V, Tuan H-F, Keser V, Wang K, Ren H, Lopez I, Zaneveld E, Siddiqui S, Bowles S, Khan A, Wang F, Fishman GA, Iannaccone A, Salvo S, Birch DG, Heckenlively JR, Jacobson SG, Traboulsi

EI, Li Y, Koenekoop RK, Chen R. Comprehensive molecular diagnosis of 189 Leber congenital amaurosis

and juvenile retinitis pigmentosa patients by targeted next-generation sequencing and clinical re-visit. J. Med. Genet. 2013; 50(10): 674-88. PMID: 23847139

72. Vishwanathan R, Iannaccone A, Scott TM, Kritchevsky SB, Jennings BJ, Carboni G, Forma G, Satterfield S, Harris

T, Johnson KC, Schalch W, Renzi LM, Rosano C, Johnson EJ, for the Health ABC Study. Relationships Among

Macular Pigment and Cognition in the Elderly. Age Ageing 2014; 43(2): 271-5 (PMID: 24435852)

73. Lucariello A, Perna A, Sellitto C, Baldi A, Iannaccone A, Cobellis L, De Luca A, De Falco M. Modulation of

wolframin expression in human placenta during pregnancy: comparison among physiological and

pathological states. BioMed Res Int 2014; doi: 10.1155/2014/985478. PMID: 24588001) 74. Domalpally A, Danis RP, Chew EY, Clemons TE, Reed S, Sangiovanni JP, Ferris FL3rd, AREDS2 Study

Group*. Evaluation of optimized digital fundus reflex photographs for lens opacities in the age-related eye

disease study 2: AREDS2 report 7. Invest Ophthalmol Vis Sci 2013;54:5989-5994 (*member, see appendix

to paper) PMID 3771555 75. AREDS2-HOME Study Research Group*, Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP,

Domalpally A, Heier JS, Kim JE, Garfinkel R. Randomized Trial of a Home Monitoring System for Early

Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study. Ophthalmology

2014; 121(2): 535-44 (*member, see appendix to paper) PMID: 24211172 76. Jackson GR, Scott IU, Kim IK, Quillen DA, Iannaccone A, Edwards JG. Diagnostic Sensitivity and

Specificity of Dark Adaptometry for detection of Age-Related Macular Degeneration. Invest. Ophthalmol. Vis.

Sci. 2014; 55(3): 1427-31. PMID: 24550363 77. Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, Domalpally A, Heier J, Kim JE, Garfinkel R;

Appendix 1 for AREDS2-HOME Study Research Group*. Randomized trial of the ForeseeHome monitoring

device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye

(HOME) study design - HOME Study report number 1. Contemp Clin Trials 2014; Feb 13 [Epub ahead of print] (*member, see appendix to paper) PMID: 24530651

78. Age-Related Eye Disease Study 2 (AREDS2) Research Group*, Chew EY, Clemons TE, Sangiovanni JP,

Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB,

Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA,

Bernstein PS, Sperduto RD. Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS2 Report No. 3. JAMA Ophthalmol. 2014; 132(2): 142-9. doi: 10.1001/jamaophthalmol.2013.7376. (*member, see appendix to paper) PMID: 24310343

79. Writing Group for the AREDS2 Research Group*, Bonds DE, Harrington M, Worrall BB, Bertoni AG,

Eaton CB, Hsia J, Robinson J, Clemons TE, Fine LJ, Chew EY. Effect of Long-Chain ω-3 Fatty Acids and

Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease

Study 2 (AREDS2) Randomized Clinical Trial. JAMA Intern Med. 2014; 174(5): 763-71. (*member, see

appendix to paper) PMID: 24638908 80. Jackson GR, Scott IU, Kim IK, Quillen DA, Iannaccone A, Edwards JG. Author response: additional

considerations in the utility of dark adaptometry for the diagnosis of age-related macular degeneration.

Invest Ophthalmol Vis Sci 2014; 55(5): 3149 [letter]. 81. Iannaccone A, Zarbin MA. Medical Therapy for Retinal Degenerative Disease: A New Era? Lancet 2014;

384(9953):1482-4. [invited editorial as comment to: “Safety and Efficacy of a Novel Oral 9-cis-retinoid

Treating Childhood Blindness due to Leber Congenital Amaurosis caused by RPE65 or LRAT mutations: a

Phase 1b Human Clinical Trial” by Koenekoop et al.] PMID: 25030841 82. Iannaccone A. Measuring Dark Adaptation in the Elderly: A Predictor of Who May Develop Macular

Degeneration? Invest. Ophthalmol. Vis. Sci. 2014; 55(8): 4790 [invited Research Highlight as comment to:

Owsley C, Huisingh C, Jackson GR, et al. Associations between abnormal rod-mediated dark adaptation

and health and functioning in older adults with normal macular health]. PMID: 25091414 83. Huntington Study Group Reach2HD Investigators*. Safety, tolerability, and efficacy of PBT2 in Huntington

disease: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015; 14(1): 39-47.

(*member, see appendix to paper) PMID: 25467848.


84. Hood MP, Kerr NC, Smaoui N, Iannaccone A. Abnormal Cone ERGs in a Family with Congenital Nystagmus and

Photophobia Harboring a p.X423Lfs Mutation in the PAX6 Gene. Doc. Ophthalmol. 2015; 130(2): 157-64. PMID: 25555363

85. Thompson DA, Ali RR, Banin E, Branham KE, Flannery JG, Gamm DM, Hauswirth WW, Heckenlively JR, Iannaccone A, Jayasundera KT, Khan NW, Molday RS, Pennesi M, Reh TA, Weleber RW, Zacks DN, for

the The Monaciano Consortium.* The Monaciano Symposium: Recommendations for Advancing Therapeutic

Strategies for Inherited Retinal Degeneration. Invest Ophthalmol Vis Sci 2015; 56(2):918-31 – * All authors equal contributors, listed in alphabetical order after first. PMID 25667399

86. Luo X, Cideciyan AV, Iannaccone A, Roman AJ, Ditta LC, Jennings BJ, Yatsenko SA, Sheplock R,

Sumaroka A, Swider M, Schwartz SB, Wissinger B, Kohl S, Jacobson SG. Blue Cone Monochromacy: visual

function and efficacy outcome measures for clinical trials. PLoS One 2015; 10(4): e0125700. (Supplemental

material available online) PMID 25909963 87. Yatsenko SA, Bakos H, Ketchum K, Kedrov M, Kishore A, Jennings BJ, Yatsenko AN, Surti U, Woods M,

Rajkovic A, Iannaccone A. Blue cone monochromacy diagnosis by high-resolution X chromosome

microarray. Clin Genet. 2015; Jul. 8. Doi: 10.1111/cge.12638 [Epub ahead of print]. (Supplemental material available online) PMID 26153062

88. Wilkin J, Kerr NC, Byrd KW, Ward JC, Iannaccone A. Characterization of a case of pigmentary retinopathy

in Sanfilippo syndrome type IIIA associated with compound heterozygous mutations in the SGSH gene.

Ophthalmic Genetics 2015; Sep 2: 1-11. [Epub ahead of print] PMID 26331342 89. Iannaccone A, Giorgianni, F, New DD, Hollingsworth TJ, Umfress A, Alhatem A, Neeli I, Lenchik NI,

Jennings BJ, Calzada JI, Satterfield S, Mathews D, Diaz RI, Harris T, Johnson KC, Charles S, Kritchevsky

SB, Gerling IC, Beranova-Giorgianni S, Radic MZ for the Health ABC Study. Circulating autoantibodies in

age-related macular degeneration recognize human macular tissue antigens implicated in autophagy,

immunomodulation, and protection from oxidative stress and apoptosis. PLoS One 2015; 10(12): e0145323. (Supplemental material available online) PMID 26717306

90. Smith TB, Parker M, Steinkamp P, Smith N, Wilson DJ, VPA Clinical Trial Study Group*, and EZ Area Study

Group. Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the

Retina of Patients with Autosomal Dominant Retinitis Pigmentosa. PLoS One 2016; 11(2): e0148022. (*member) PMID 26845445.

91. Iannaccone A, Carboni G, Forma G, Mutolo MG, Jennings BJ. Macular Pigment Optical Density and

Measures of Macular Function: Test-Retest Variability, Cross-Sectional Correlations, and Findings from

the Zeaxanthin Pilot Study of Response to Supplementation (ZEASTRESS-Pilot). Foods 2016; 5, 32;

doi:10.3390/foods5020032. PMID assignment in progress 92. Iannaccone A, Koirala D, Hollingsworth TJ, New DD, Lenchik NI, Beranova-Giorgianni S, Gerling IC,

Giorgianni F, Radic MZ. Retinal pigment epithelium and microglia express the CD5 antigen-like protein,

a novel autoantigen in age-related macular degeneration. Exp. Eye Res. (submitted) 93. Balem F, Tirupula K, Yanamala N, Man D, Ollesch J, Planas-Iglesias J, Waseem N, Jennings BJ, Gerwert

K, Bhattacharya SS, Iannaccone A, Klein-Seetharaman J. Molecular Properties and Disease Phenotypes of

Rhodopsin Retinitis Pigmentosa Mutants P23H and N15S. PLoS ONE (submitted) 94. Rafietaary S, Barnett JM, Kerr NC, Iannaccone A. Retinal Changes and Nerve Fiber Layer Loss in

Pediatric Patients on Vigabatrin: An electroretinogram and imaging study. JAAPOS (in preparation).

95. Epstein SR, Sollenberger EL, Jennings BJ, Sharp J, Adamus G, Iannaccone A. Clinical, functional, and

imaging findings in cancer cancer-associated retinopathy (CAR) and optic neuropathy (CAON).

Ophthalmology (under revision) 96. Smith CT, Kerr NC, Chiang J, Iannaccone A. Early stage electroretinogram and high-resolution imaging

findings in a pediatric case of KCNV2-associated retinopathy. Ophthalmic Genetics (in preparation)

97. Sollenberger EL, Birg A, Carboni G, Forma G, Adamus G, Iannaccone A. Spectral-Domain Optical

Coherence Tomography Findings in Patients with Autoimmune Neuro-Retinopathy. Invest. Ophthalmol. Vis.

Sci. (in preparation) 98. Sollenberger EL, Epstein SR, Carboni G, Forma G, Jennings BJ, Adamus G, Iannaccone A. Clinical

and functional presentation of autoimmune neuro-retinopathies. Am. J. Ophthalmol. (under revision)

99. Iannaccone A, Cox KF, Bratton M, Byrd A, Gallaher KT, Satterfield S, Johnson KC, Harris T, Johnson EJ,

Kritchevsky SB, for the Health ABC Study. Macular Pigment Optical Density in Age-Related Maculopathy.

(in preparation).


100. Iannaccone A, Bratton M, Johnson EJ, Byrd A, Gallaher KT, Kenyon E, Harris T, Satterfield S, Johnson

KC, Kritchevsky SB for the Health ABC study. Correlates of Macular Pigment Optical Density in the Elderly.

(in preparation). 101. Iannaccone A, Byrd A, Bratton M, Johnson EJ, Gallaher KT, Satterfield S, Kenyon E, Harris T, Johnson

KC, Kritchevsky SB. Inter-Racial Differences in the Relationship Between Macular Pigment Optical Density,

C-Reactive Protein and Serum Levels of Macular Carotenoids in Elderly Subjects (in preparation). 102. Iannaccone A, Bratton M, Schneck K, Wirotsko W, Stone EM, Sidjanin DJ. Adult-Onset Macular

Dystrophies: Novel Mutations in the RDS/Peripherin Gene and Comparison to non-RDS/Peripherin-linked

Phenotypes. (under revision).

Other Published Manuscripts 1. Pernini C, Leone G, Forte F, Ciccarelli ML, Iannaccone A. Validità dell'impiego della campimetria

computerizzata negli screening di base [Italian]. Proceedings of the IX Refreshment Course of the Italian

Orthoptist Association (AIO) 'La pratica perimetrica', Genova, May 11-12 1989, Giornale Italiano di Ortottica e

Tecnica Strumentale Oftalmica, 1991; 16: 28-31. 2. Rispoli E, Vingolo EM, Rispoli D, Iannaccone A. Sodium Hyaluronate (Hyalistil) in performing ERG

[Italian]. Boll. Ocul. 1991; 3: 625-630.

3. Rispoli E, Vingolo EM, Iannaccone A. Thymopentin in Retinitis Pigmentosa. Evaluation of its possible

therapeutical effects after 18 months of treatment, preliminary results. New Trends in Ophthalmology 1991;

6: 235-241. 4. Rispoli E, Iannaccone A, Di Battista V, Di Pasqua F. Clinical applications of electrofunctional techniques in

the evaluation of amblyopia [Italian]. Boll. Ocul. 1992; 71: 897-911.

5. Rispoli E, Iannaccone A, Moretti S, Vingolo EM. The electroretinogram in retinitis pigmentosa: case

report [Italian]. Boll. Ocul. 1993; 72 (Suppl. 1): 37-49.

6. Vingolo EM, Pescosolido N, Iannaccone A. Evaluation of intraocular pressure in patients affected with

retinitis pigmentosa [Italian]. Boll. Ocul. 1993; 72 (Suppl. 1): 123-134.

7. Vingolo EM, Iannaccone A, Forte R, Pannarale L. Thymopentin: a new therapeutic approach to

retinitis pigmentosa [Italian]. Boll. Ocul. 1993; 72 (Suppl. 1): 141-155.

8. Proto F, Iannaccone A, Giusti C, De Leo A, Vingolo EM. Kearns-Sayre Syndrome (KSS): case report

and review of the literature [Italian]. Ann.Ottalmol. Clin. Ocul. 1994; 120: 149-154.

9. Mutolo PA, Ciccarelli ML, Iannaccone A. Schubert-Bornschein complete congenital stationary night blindness (SB-

CSNB1) and tilted disc syndrome. A case report [Italian]. Ann.Ottalmol. Clin. Ocul. 1994; 120: 421-431. 10. Forte R, Iannaccone A, De Propris G, Del Beato P, Rinaldi R, Roncati S, Vingolo EM, Pannarale MR. The

optic nerve in patients with the Laurence-Moon-Bardet-Biedl phenotype: a clinical and functional study.

[Italian] Boll. Ocul. 1996; 75 (suppl. 4): 115-124. 11. Iannaccone A, Forte R, Spaccini L, Tanzilli P, Vingolo EM, Roncati S, Rispoli E. Autosomal dominant cone

dystrophy mimicking optic atrophy: description of a genealogy. [Italian] Boll. Ocul. 1996; 75 (suppl. 4):

147-158. 12. Mutolo PA, Ciccarelli ML, Iannaccone A, Santamaria S, Cataldi C. Monocular familial Brown syndrome:

description of a genealogy [Italian]. Proceedings of the XIV Congress of the Italian Society of Pediatric

Ophthalmology (SIOP), Parma, May 29-31, 1997. Casa Editrice Mattioli, Fidenza (PR), Italy: pp. 203-210. 13. Iannaccone A. Retinitis Pigmentosa. Invited Update to Review No. 21. National Organization for

Rare Disorders, Inc., Danbury, CT, www.rarediseases.org; Jan. 2009

14. Iannaccone A. Retinitis Pigmentosa. Invited Update to Review No. 21. National Organization for

Rare Disorders, Inc., Danbury, CT, www.rarediseases.org; Aug. 2012

15. Iannaccone A. Optical Coherence Tomography in Rare Pediatric Cases. Retina Today 2012; Sept. issue, p.1-

3 (cover article).


Books, Book Chapters and Meeting Proceedings 1. Rispoli E, Iannaccone A, Moretti S. Problematiche di registrazione dell'ERG nella retinite pigmentosa:

innovazioni tecnologiche [Italian]. In: Cordella M, Baratta G, Macaluso C, eds., Retinite Pigmentosa,

movimenti oculari e ambliopia, glaucoma, Casa Editrice Mattioli, Fidenza, 1991, p. 253-262. 2. Rispoli E, Vingolo EM, Onori P, Iannaccone A, Steindl K. Comparazione di alcuni parametri clinici e

strumentali nella Retinite Pigmentosa: ERG ed alterazioni del campo visivo [Italian]. In: Cordella M, Baratta

G, Macaluso C, eds., Retinite Pigmentosa, movimenti oculari e ambliopia, glaucoma, Casa Editrice Mattioli,

Fidenza, 1991, p. 263-273. 3. Pannarale MR, Rispoli E, Vingolo EM, Pannarale L, Forte R, Iannaccone A. Cataract complicated by

retinitis pigmentosa. In: Humphries, Bhattacharya, Bird, eds., Degenerative Retinopathies: Advances in

Clinical and Genetic Research. CRC Press, Boca Raton, 1992; pp. 145-149. 4. De Propris G, Iannaccone A, Amodeo S, Onori P, Pierazzi C. Clinical observations in 10 cases of

Laurence-Moon-Bardet-Biedl Syndrome. [Italian] Proceedings of the 72nd National Congress of the Italian

Society of Ophthalmology. Arti Grafiche Dial, Mondovì (Cuneo), 1993, p. 1089-1100. 5. Forte R, Onori P, Steindl K, Iannaccone A, Pierazzi MC, De Ruggieri G, Grammatico P. Visual acuity in

retinitis pigmentosa patients with defined inheritance pattern. In: E. Rinaldi, ed.: Retinitis Pigmentosa.

Present knowledge and outlook, Edizioni Liviana Medicina, Naples, 1993; pp. 262-272. 6. Steindl K, Grammatico B, Forte R, Iannaccone A, Vingolo EM. Gyrate atrophy: clinical and genetic

aspects. In: E. Rinaldi, ed.: Retinitis Pigmentosa. Present knowledge and outlook, Edizioni Liviana

Medicina, Naples, 1993; pp. 345-350. 7. Vingolo EM, Iannaccone A, Forte R, Tanzilli P, Sciò F. Thymopentin in the treatment of retinitis pigmentosa:

Results after a three-year follow-up. In: E. Rinaldi, ed.: Retinitis Pigmentosa. Present knowledge and outlook,

Edizioni Liviana Medicina, Naples, 1993; pp. 437-445. 8. Del Porto G, Vingolo EM, David D, Steindl K, Wedemann H, Forte R, Iannaccone A, Gal A, Pannarale MR.

Clinical features of autosomal dominant retinitis pigmentosa associated with the Gly-188-Arg mutation of

the rhodopsin gene. In: Hollyfield JG, La Vail MM, Anderson RE, (eds) Retinal Degeneration: Clinical and

Laboratory Applications. Plenum Press, New York, 1993; pp. 91-101. 9. Iannaccone A, Vingolo EM. Psychophysical determination of visual function in patients with tapetoretinal

degenerations [Italian]. In: Sviluppo ed alterazione della visione, Proceedings of the 25th Meeting of the

Italian Orthoptist Association. Verduci Editore, Rome, 1994, p. 249-253. 10. Vingolo EM, Pannarale L, Forte R, Iannaccone A, Pannarale MR. The immune system and retinitis

pigmentosa: Pathophysiological bases for new therapeutic approaches. [Italian] Proceedings of the 73rd

National Congress of the Italian Society of Ophthalmology. Arti Grafiche Dial, Mondovì (Cuneo), 1994, p. 379-389.

11. Cassone-Faldetta M, Gobbi F, Laurenti O, Pannarale L, Iannaccone A, Vingolo EM. Central retinal vein

occlusion in chronic lymphoid leukemia (CLL): case report. Proceedings of the 12th Congress of the

European Association of Internal Medicine. ELA, Grupo Aran, Madrid, 1995: p. 337-341. 12. Vingolo EM, Bellelli A, Pannarale L, Iannaccone A, Forte R, Santori M, Grenga R. Cataractogenesis in

retinitis pigmentosa: spectroscopic fluorescence analysis of aqueous humor composition. In: Anderson RE,

LaVail MM, Hollyfield JG, eds, Degenerative Diseases of the Retina. Plenum Press, New York, 1995: 403-407. 13. Iannaccone A, Vingolo EM, Grammatico B, Forte R, Tanzilli P, De Bernardo C, Rispoli E, Del Porto G,

Pannarale MR. Scotopic threshold responses and rod intensity-response functions as sensitive indicators

of the carrier status in X-linked recessive retinitis pigmentosa. In: Anderson RE, LaVail MM, Hollyfield JG,

eds, Degenerative Diseases of the Retina. Plenum Press, New York, 1995: 371-376. 14. Tanzilli P, Iannaccone A, Rispoli E, Del Beato P, Vingolo EM. Cone-rod dystrophy with progressive selective

involvment of the OFF cone system. [Italian] Proceedings of the 74th National Congress of the Italian Society of

Ophthalmology, Rome, November 17-20, 1994. Casa Editrice Mattioli, Fidenza (PR), Italy, 1995: 705-714.

15. Iannaccone A, Vingolo EM, Tanzilli P, Del Beato P, Pannarale MR. Long-term results of a pilot study on

thymopentin in the treatment of retinitis pigmentosa: pathophysiological considerations [Italian] Proceedings

of the IV National Congress of the Italian Association for Ocular Pharmacology (AISFO), Isola di Capri,

October 13-15 1994. Mediconsult, Catania, Italy, 1996; p. 461-473. 16. Iannaccone A, Falsini B, Haider N, Del Porto G, Stone EM, Sheffield VC. Bardet-Biedl syndrome. Phenotypic

characteristics associated with the BBS4 locus. In: Hollyfield JG, La Vail MM, Anderson RE, eds, Retinal

Degenerative Diseases and experimental Therapy. Kluwer Academic/Plenum Press, New York, 1999: pp. 187-199.


Published and presented abstracts 1. Iannaccone A, Tanzilli P, Rispoli M. ERG recording: low-noise techniques in retinitis pigmentosa

Invest. Ophthalmol. Vis. Sci. 1992; 33 (4 Suppl): 840. 2. Vingolo EM, Iannaccone A, Onori P, Steindl K, Rispoli E. Correlations between perimetric and

electroretinographic measurements in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 1992; 33 (4 Suppl): 840.

3. Vingolo EM, Rispoli EM, Iannaccone A, Steindl K, Tanzilli P, Del Porto G, Pannarale MR. Scotopic threshold

response abnormalities in X-linked RP carriers. Invest. Ophthalmol. Vis. Sci. 1993; 34 (4 Suppl.): 1271. 4. Iannaccone A, Rispoli E, Vingolo EM, Onori P, Pannarale MR. Progressive night blindness and

supernormal ERG responses: a case report. Invest. Ophthalmol. Vis. Sci. 1993; 34 (4 Suppl.): 1271. 5. De Propris G, Iannaccone A, Vingolo EM, Amodeo S, Leonardi A, Pannarale MR. Ophthalmological features

of the Laurence-Moon-Bardet-Biedl phenotype. Invest. Ophthalmol. Vis. Sci. 1993; 34 (4 Suppl.): 1369. 6. Vingolo EM, Palestini M, Scalfati M, Mechella M, Iannaccone A, Teofili MT, Forte R. Epithelial corneal

abnormalities in Alport’s syndrome: a case report. SPOVS Proceedings. Proc. Vis. Sci. 1993; p.11.

7. Forte R, Vingolo EM, Iannaccone A, Gobbi F, Rispoli E, Pannarale MR. Contrast sensitivity function for the clinical evaluation of cystoid macular edema in retinitis pigmentosa. Proposal of a new therapeutic approach by Deflazacort. SPOVS Proceedings. Proc. Vis. Sci. 1993; p. 28.

8. Iannaccone A, Vingolo EM, Tanzilli P, Rispoli E. The Scotopic Threshold Response in different forms

of Congenital Stationary Night Blindness. Invest. Ophthalmol. Vis.Sci. 1994; 35 (4 Suppl.): 1377. 9. Vingolo EM, Iannaccone A, De Propris G, Tanzilli P, Rispoli E, Pannarale MR. Electroretinographic

abnormalities in the Laurence-Moon-Bardet-Biedl phenotype. Invest. Ophthalmol. Vis.Sci. 1994; 35 (4 Suppl.): 1958.

10. Forte R, Pannarale L, Iannaccone A, Vingolo EM, Santi G, Pannarale MR. Cystoid macular edema in

retinitis Pigmentosa: clinical and functional evaluation of patients treated with deflazacort. Invest. Ophthalmol. Vis.Sci. 1994; 35 (4 Suppl.): 1958.

11. Rispoli E, Vingolo EM, Iannaccone A, Forte R, Grammatico B, De Bernardo C, Steindl K, Pannarale

MR. Electroretinographic measures in carriers of X-linked recessive retinitis pigmentosa Invest. Ophthalmol. Vis.Sci. 1994; 35 (4 Suppl.): 2159.

12. Iannaccone A, Vingolo EM, Tanzilli P, Forte R, Rispoli E. Steady-state flash visual evoked potentials in the

Laurence-Moon-Bardet-Biedl syndrome. Preliminary observations. 5th International Evoked Potentials Symposium, Milan, Italy, September 4-7, 1994: p. 56.

13. Rispoli E, Iannaccone A, Vingolo EM, Rispoli M. Rod ERG frequency-response function: normative data and

clinical applications. Invest. Ophthalmol. Vis. Sci. 1995; 36: S446. 14. Vingolo EM, Iannaccone A, Rispoli E, Grammatico B, Pannarale L, De Bernardo C. Different rod pathways’

abnormalities in RP2 and RP3 XLRP carriers. Invest. Ophthalmol. Vis. Sci. 1995; 36: S925. 15. Iannaccone A, Vingolo EM, Forte R, Rispoli M, Arrico L, Rispoli E. Clinical and electroretinographic

findings in the Goldmann-Favre vitreoretinal dystrophy. Invest. Ophthalmol. Vis. Sci. 1995; 36: S926. 16. Iannaccone A, Cideciyan AV, Sheffield VC, Stone EM, Jacobson SG. Phenotype of chromosome 8q-

linked autosomal dominant retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 1996; 37 (suppl. 4): S345. 17. Lyubarsky A, Iannaccone A, Chen J, Xu J, Pugh EN. Cone PII component of murine ERG isolated by

flashed background. Soc. Neurosci. Abs. 1996: 22 (Part 1): 121. 18. Haider N, Kwitek-Black AE, Iannaccone A, Carmi A, Elbedour K, Nishimura DY, Stone EM, Sheffield VC.

Genetic and physical fine mapping of the chromosome 15 Bardet-Biedl syndrome (BBS4) locus. Am. J. Hum. Genet. 1996; 59: A220.

19. Iannaccone A, Grunwald JE, DuPont J. The effect of 5-isosorbide monitrate (ISMO) on optic nerve head

and foveal choroidal blood flow. Invest. Ophthalmol. Vis. Sci. 1997; 38 (suppl. 4): S275. 20. Iannaccone A, Letizia C. Plasma endothelin-1 concentrations in patients with retinal vascular disease.

Proceedings of the University of Tennessee-Memphis Research Day, Memphis, TN, Nov. 21, 1997, p. 17. 21. Iannaccone A. Clinical manifestations of autosomal dominant retinitis pigmentosa associated with distinct

rhodopsin gene mutations. Proceedings of the University of Tennessee-Memphis Research Day, Memphis, TN, Nov. 21, 1997, p. 18.

22. Iannaccone A. Correlation between Goldmann perimetry and Maximal ERG response in patients with Usher

syndrome. Proceedings of the University of Tennessee-Memphis Research Day, Memphis, TN, Nov. 21, 1997, p. 18.

23. Iannaccone A. Rod-driven and extramacular contributions to the 10-Hz flash visual evoked potential. Invest.

Ophthalmol. Vis. Sci. 1998; 39 (suppl. 4): S185. 24. Iannaccone A. Phenotypical differences in autosomal dominant retinitis pigmentosa associated with distinct

rhodopsin mutations. Exp. Eye Res. 1998; 67 (Suppl. 1): S.235.


25. Iannaccone A, Falsini B, Heider N, Iarossi G, Stone EM, Sheffield VC. Phenotypic manifestations of

Bardet-Biedl syndrome associated with the BBS4 locus [ARVO abstract]. Invest. Ophthalmol. Vis. Sci. 1999;

40 (4): S721. 26. Ervin CS, Wohabrebbi A, Iannaccone A, Jablonski MM. Brimonidine rescues photoreceptors from

degeneration induced by retinal pigment epithelial removal in vitro [ARVO abstract]. Invest. Ophthalmol. Vis.

Sci. 1999; 40 (4): S160. 27. Lyubarsky AL, Krasnoperova NV, Lem J, Chen J, Iannaccone A, Pugh EN, Jr. Functionally rodless mice as

models for studies of cone function. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2000; 41(4 Suppl): S112.

28. Jacobson SG, Cideciyan AV, Iannaccone A, Weleber RG, Fishman GA, Maguire AM, Affatigato LM, Bennett

J, Pierce EA, Danciger M, Farber DB, Stone EM. Disease expression of RP1 mutations causing retinitis

pigmentosa. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2000; 41(4 Suppl): S193. 29. Iannaccone A, Swain PK, Baldi A, Conciatori M, Ciccarelli ML, Swaroop A. Autosomal dominant cone-

rod dystrophy with cystoid macular edema. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2000; 41(4

Suppl): S882.

30. Parker TA, Iannaccone A. Correlation between Goldmann visual field size and maximal ERG response in

patients with Usher syndrome. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2000; 41(4 Suppl): S890.

31. Iannaccone A, Ciccarelli ML, Orten DJ, Weston MD, Baldi A, Jablonski MM, Kimberling WJ. Kinetics of visual field

loss in Usher syndrome type 2. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2001; 42(4 Suppl): S77. 32. Wohabrebbi A, Iannaccone A, Jablonski MM. Downregulation of a novel photoreceptor protein

correlates with improper outer segment assembly. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2001;

42(4 Suppl): S192.

33. Ezzeldin H, King JL, Coan P, Millender-Swain T, Baldi A, Iannaccone A, Jacobson SG, Pittler SJ. Promoter

and mutational analysis of the photoreceptor guanylate cyclase I gene. [ARVO abstract] Invest. Ophthalmol.

Vis. Sci. 2001; 42(4 Suppl): S353. 34. Jablonski MM, Graney MJ, Kritchevsky SB, Iannaccone A. Reliability assessment of a rod photoreceptor

outer segment grading system. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2001; 42(4 Suppl): S364.

35. Iannaccone A, Yashar BM, Ciccarelli ML, Bingham EL, Gasparri V, Baldi A, Jablonski MM, Ayyaggari R,

Sieving PA. Phenotype of X-Linked Juvenile Retinoschisis (XLRS) Associated With RS1 Missense

Mutations. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2002; 43: E-Abstract 1181. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch=true 36. Wohabrebbi A, Umstot ES, Iannaccone A, Desiderio DM, Jablonski MM. Characterization of the XAP-1

antigen using differential centrifugation, second-dimensional gel electrophoresis, and MALDI-TOF MS.

[ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2002; 43: E-Abstract 1407. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch=true 37. Jablonski MM, Iannaccone A, Wang XF. Lactose Support of Photoreceptor Outer Segment Assembly

Demonstrates Characteristics of a Receptor-mediated Phenomenon. [ARVO abstract] Invest. Ophthalmol.

Vis. Sci. 2002; 43: E-Abstract 3737. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch= true 38. Wang XF, Iannaccone A, Wohabrebbi A, Jablonski MM. Human Anti-Photoreceptor (HAP-1) Expression in

Human Retinas. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2002; 43: E-Abstract 3747. Free access

online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 39. Lotery AJ, Jacobson SG, Weleber RG, Iannaccone A, Namperumalsamy P, Fishman GA, Levin A, Lam BL,

Heon E, Stone EM. Prevalence of Mutations in the RPE65, CRX, AIPL1, TULP1, GUCY2D and CRB1 Genes

in Leber Congenital Amaurosis. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2003; 44: E-Abstract 2301.

Free access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 40. Iannaccone A, Breuer DK, Wang XF, Kuo SF, Normando EM, Cosgrove D, Baldi A, Morton CC, Swaroop

A, Jablonski MM. Clinical and Immunohistochemical Evidence for an X-linked Retinitis Pigmentosa

Syndrome with Recurrent Infections and Hearing Loss in Association with an RPGR Mutation. [ARVO

abstract] Invest. Ophthalmol. Vis. Sci. 2003; 44: E-Abstract 4871. Free access online at:

http://www.iovs.org/search.dtl? arvomtgsearch=true 41. Jablonski MM, Wang XF, Lu L, Pardue M, Iannaccone A, Goldowitz D, Williams RW, Tennessee

Mouse Genome Consortium. Regional Mutagenesis of the Mouse Genome: An Update of Ocular

Phenotypes. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2003; 44: E-Abstract 4917. Free access

online at: http://www.iovs.org/search.dtl?arvomtgsearch=true


42. Reynolds DH, Wang XF, Iannaccone A, Reiner A, Jablonski MM. Age-Related Decline of the

Submacular Vasoactive Neural Network. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2004; 45: E-

Abstract 55. Free access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 43. Meng S, Satterfield S, Iannaccone A, Kenyon E, Harris T, Newman A, Simonsick E, Kritchevsky SB, for the

Health ABC Study. Self-reported and measured visual function and walking difficulty in community-dwelling

older adults. [SER (Society for Epidemiologic Research) abstract] Am. J. Epidemiol. 2004; S2 (Abstract 005)

- Free access online at: http://www.epiresearch.org/meeting/abstractbook.pdf 44. Mura M, Sereda C, MacDonald IM, Iannaccone A. Clinical and functional findings in a family with

choroideremia due to a deletion of the entire CHM gene. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2005;

46: E-Abstract 534. Free access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 45. Iannaccone A, Gallaher K, Mura M, Kenyon E, Harris TL, Todd WA, Harris T, Johnson KC, Satterfield S,

Kritchevsky SB. Macular Pigment Optical Densitometry in the Elderly: Findings in a Large Biracial Mid-South

Sample and Effect of Optical Blur in Pseudophakic Subjects. [ARVO abstract] Invest. Ophthalmol. Vis. Sci.

2005; 46: E-Abstract 1567. Free access online at: http://www.iovs.org/search.dtl?arvomtgsearch= true 46. Gallaher K, Mura M, Todd WA, Kenyon E, Harris TL, Satterfield S, Harris T, Johnson KC, Kritchevsky SB,

Iannaccone A. Test-Retest Variability of Macular Pigment Optical Densitometry in the Elderly: Findings from

the Health ABC ARMA Study. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2005; 46: E-Abstract 1570. Free

access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 47. Wang XF, Iannaccone A, Jablonski MM. Contribution of Müller cells toward the regulation of

photoreceptor assembly. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2005; 46: E-Abstract 3978. Free

access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 48. Iannaccone A, Jennings BJ, Waseem N, Gallaher K, Reese E, Bhattacharya SS. Retinitis pigmentosa:

Variability in phenotypes associated with rhodopsin mutations. 10th

Annual Vision Research Conference

Rhodopsin - Advances and Perspectives. Greater Fort Lauderdale/ Broward County Convention Center, FL, 28 – 29 April, 2006.

49. Iannaccone A, Johnson EJ, Perry SE, Gallaher K, Kenyon E, Harris T, Satterfield S, Yeum K-J, Johnson

KC, Kritchevsky SB. Correlates of Macular Pigment Optical Density in the Elderly. [ARVO abstract] Invest.

Ophthalmol. Vis. Sci. 2006; 46: E-Abstract 3800. Free access online at: http://www.iovs.org/search.dtl?

arvomtgsearch=true 50. Gallaher K, Mura M, Armstrong J, Todd WA, Satterfield S, Kenyon E, Harris T, Johnson KC, Kritchevsky SB,

Iannaccone A. Macular Pigment Optical Density in Age-Related Maculopathy: Findings from the Health

ABC Study. [ARVO abstract] Invest. Ophthalmol. Vis. Sci. 2006; 46: E-Abstract 5668. Travel Award

recipient. Free access online at: http://www.iovs.org/search.dtl? arvomtgsearch=true 51. Iannaccone A, Sahu PD, Atkins S, Wang X-F, Ayyagari R, Jablonski MM. Evidence for cone and rod

dysfunction in autosomal dominant Stargardt-like disease associated with a 5-bp deletion in ELOVL4.

XVII International Congress of Eye Research, Buenos Aires, Argentina, October 29 – November 4, 2006. 52. Jablonski MM, Iannaccone A, Reynolds DH, Gallaher P, Allen S, Wang XF, Reiner AJ. Age-related decline

of VIP-positive submacular vasoactive neural networks. XVII International Congress of Eye Research,

Buenos Aires, Argentina, October 29 – November 4, 2006. 53. Renzi LM, Iannaccone A, Gallaher KT, Satterfield S, Kenyon E, Harris T, Johnson KC, Kritchevsky SB,

Schalch W, Johnson EJ. Relationships Among Macular Pigment Optical Density (MPOD), Serum Lutein (L),

Zeaxanthin (Z), and n3 Fatty Acids (FAs). Invest. Ophthalmol. Vis. Sci. 2007; 48: E-Abstract 2123. Free

access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 54. Gallaher KT, Johnson EJ, Satterfield S, Kenyon E, Harris T, Yeum K-J, Johnson KC, Kritchevsky SB,

Iannaccone A. Inter-Racial Differences in the Relationship Between Macular Pigment Optical Density, C-

Reactive Protein, and Serum Levels of Macular Carotenoids in Elderly Subjects. Invest. Ophthalmol. Vis.

Sci. 2007; 48: E-Abstract 2125. Free access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 55. Iannaccone A, Johnson EJ, Gallaher KT, Armstrong J, Kenyon E, Harris T, Yeum K-J, Satterfield S,

Johnson KC, Kritchevsky SB. Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP),

and Serum Lutein and Zeaxanthin (L&Z) in Age-Related Maculopathy (ARM). Invest. Ophthalmol. Vis. Sci.

2007; 48: E-Abstract 2147. Free access online at: http://www.iovs.org/search.dtl? arvomtgsearch=true 56. Sidjanin DJ, Schneck K, Reese E, Iannaccone A. Novel Mutations in the RDS-Peripherin Gene in Adult-

Onset Macular Dystrophies. Invest. Ophthalmol. Vis. Sci. 2007; 48: E-Abstract 3699. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch=true


57. Fung KH, Stone EM, Iannaccone A. Enhanced-S Cone Syndrome (ESCS): 40-Year Retrospective Follow-Up

Data, Adult-Onset Acute Development of Macular Retinoschisis (RS), and Response to Treatment With

Acetazolamide. Invest. Ophthalmol. Vis. Sci. 2007; 48: E-Abstract 3704. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch=true 58. Man D, Gallaher KT, Yanamala N, Waseem N, Jennings BJ, Reese E, Gerwert K, Bhattacharya SS,

Iannaccone A, Klein-Seetharaman J. Molecular Properties and Disease Phenotypes of Rhodopsin Mutants

P23H and N15S Associated With Autosomal Dominant Retinitis Pigmentosa (ADRP). Invest. Ophthalmol. Vis.

Sci. 2007; 48: E-Abstract 3720. Free access online at: http://www.iovs.org/search.dtl? arvomtgsearch=true 59. Philp AR, Jin M, Li S, Roos BR, Iannaccone A, Weleber R.G, Fishman GA, Jacobson SG, Travis GH, Stone

EM. Disease-Causing Mutations in the RPE65 Gene Abolish Retinoid Isomerase Activity. Invest. Ophthalmol.

Vis. Sci. 2007; 48: E-Abstract 2960. Free access online at: http://www.iovs.org/search.dtl?

arvomtgsearch=true’ 60. Armstrong JT, Deaton-Cantrell AM, Iannaccone A. A Pilot Study on the Effect of Lutein and

Zeaxanthin Supplementation on Psychophysical and Electrophysiological Macular Outcome Measures.

Invest. Ophthalmol. Vis. Sci. 2008; 49: E-Abstract 4964. Free access online at:

http://www.iovs.org/search.dtl? arvomtgsearch=true 61. Iannaccone A, Johnson EJ, Armstrong JT, Kenyon E, Harris T, Satterfield S, Johnson KC, Kritchevsky

SB. Macular Pigment Optical Density, C-Reactive Protein, and Serum Lutein and Zeaxanthin in the Elderly.


http://www.iovs.org/search.dtl? arvomtgsearch=true 62. Iannaccone A, Miyake N, Ciccarelli ML, Cheng L, Andrews C, Campioni M, Baldi A, Kerr NC, Engle EC.

Autosomal dominant Duane Retraction Syndrome (adDRS): Phenotypic and molecular effects of the

G228S mutation in the CHN1 (DURS2) gene. AAPOS meeting, San Francisco, CA, April 17-21, 2009. 63. Iannaccone A, Spencer K, Olson LM, Armstrong JT, Johnson KC, Kenyon E, Satterfield S, Johnson EJ,

Kritchevsky SB, Haines JL. Y402H Variant in Complement Factor H (CFH): Association with Age-Related

Maculopathy (ARM) and Correlation with Macular Pigment Optical Density (MPOD), Serum C-Reactive

Protein (CRP), Lutein & Zeaxanthin (L&Z). Invest. Ophthalmol. Vis. Sci. 2009; 50: E-Abstract 961. Free

access online at: http://www.iovs.org/search.dtl? arvomtgsearch=true 64. Radhakrishnan-Iyer SS, Laing AE, Adamus G, Iannaccone A. Clinical Characteristics Of Patients With Auto-

immune Retinopathies (AIR) And Neuropathies (AIN): Differential Diagnosis With Retinitis Pigmentosa (RP).

Invest. Ophthalmol. Vis. Sci. 2009; 50: E-Abstract 975. Free access online at: http://www.iovs.org/search.dtl?

arvomtgsearch=true 65. Haines JL, Spencer K, Olson LM, Agarwal A, Postel EA, Iannaccone A, Satterfield S, Johnson KC,

Kritchevsky SB, Pericak-Vance MA. Progress in Predicting Risk for Age-Related Macular Degeneration.


http://www.iovs.org/search.dtl? arvomtgsearch=true 66. Kerr NC, Iannaccone A, Calzada JI, Kinnick TR, Stone EM. Bilateral Neovascular Membranes in a Child

With Early-onset Autosomal Recessive Best's Vitelliform Macular Dystrophy (arBVMD) Due to Compound

Heterozygosity for VMD2/BEST1 Mutations. Invest. Ophthalmol. Vis. Sci. 2009; 50: E-Abstract 6271. Free

access online at: http://www.iovs.org/search.dtl? arvomtgsearch=true 67. Kerr NC, Iannaccone A, Kinnick TR, Calzada JI, Stone EM. Early-onset Autosomal Recessive Best's

Vitelliform Macular Dystrophy (arBVMD) Due to Compound Heterozygosity for VMD2/BEST1 Mutations

Complicated by Bilateral Neovascular Membranes. World Congress of Pediatric Ophthalmology and

Strabismus, CCIB Congress Center, Barcelona, Spain, Sept. 12-13, 2009. 68. Radhakrishnan-Iyer S, Carboni G, Forma G, Laing AE, Adamus G, Iannaccone A. Clinical Characteristics

of Patients with Autoimmune Neuroretinopathy (AINR). American Academy of Ophthalmology meeting, San

Francisco, CA, Oct. 24-28, 2009. 69. Mutolo MG, Forma G, Carboni G, Jennings BJ, Iannaccone A. Macular Pigment Optical Density (MPOD)

Testing in Middle-Aged Adults: Comparison Between a Standard Heterochromatic Flicker Photometry

(Std-HFP) Method and the QuantifEYE®

(QE), a Desktop Device Designed for Clinical Applications.

Invest. Ophthalmol. Vis. Sci. 2010; 51: E-Abstract 1287. Free access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true

70. Carboni G, Forma G, Mutolo MG, Jennings BJ, Iannaccone A. Cross-Sectional Correlations Between

Macular Pigment Optical Density (MPOD) and Measures of Macular Function. Invest. Ophthalmol. Vis. Sci.

2010; 51: E-Abstract 1293. Free access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true


71. Brumm MV, Branham K, Othman M, Karoukis AJ, Weleber RG, Iannaccone A, Jacobson SG, Swaroop A,

Heckenlively JR. X-Linked Recessive Mutations in Simplex Males With Retinitis Pigmentosa. Invest.

Ophthalmol. Vis. Sci. 2010; 51: E-Abstract 1399. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch=true 72. Forma G, Carboni G, Mutolo MG, Jennings BJ, Iannaccone A. Test-Retest Variability of Measures of

Macular Function: Baseline Findings From the Zeaxanthin Pilot Study of Response to Supplementation

(ZEASTRESS-Pilot). Invest. Ophthalmol. Vis. Sci. 2010; 51: E-Abstract 2801. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch=true 73. Rhadakrishnan-Iyer SS, Forma G, Carboni G, Mutolo MG, Adamus G, Iannaccone A. Patterns of Visual

Function Loss in Autoimmune Neuro-Retinopathy (AINR): Psychophysical and Electrophysiological

Findings. Invest. Ophthalmol. Vis. Sci. 2010; 51: E-Abstract 3547. Free access online at:

http://www.iovs.org/search.dtl?arvomtgsearch=true 74. Adamus G, Brown L, David L, Schiffman J, Iannaccone A. Identification of Novel Antigenic Targets for

Autoantibodies Against Optic Nerve Antigens in Autoimmune Neuro-Retinopathy. Invest. Ophthalmol. Vis.

Sci. 2010; 51: E-Abstract 5780. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 75. Iannaccone A, Neeli I, Lenchik N, Krishnamurthy P, Gerling IC, Radic MZ. Serological Patterns of

Autoreactivity and Identification of Novel Auto-Antigens in Age-Related Macular Degeneration (AMD).

Invest. Ophthalmol. Vis. Sci. 2010; 51: E-Abstract 6202. Free access online at: http://www.iovs.org/

search.dtl?arvomtgsearch=true 76. Iannaccone A, Neeli I, Krishnamurthy P, Lenchik N, Wan H, Gerling IC, Desiderio DM, Radic MZ.

Autoimmunity in Age-Related Macular Degeneration: A Possible Role Player in Disease Development

and Progression. XIVth International Symposium on Retinal Degeneration, Mont-Tremblant, Quebec,

Canada, July 13-17, 2010. 77. Rhadakrishnan-Iyer SS, Forma G, Carboni G, Mutolo MG, Adamus G, Iannaccone A. Patterns of

Visual Field Patterns and Electrophysiological Findings in Autoimmune Neuro-Retinopathy (AINR).

American Academy of Ophthalmology meeting, Chicago, IL, Oct. 16-19, 2010. 78. Omar A, Wang Z, Racine J, Iannaccone A, Lopez I, den Hollander A, Majewski J, Koenekoop RK.

Combining Homozygosity Mapping With Exome Capture To Identify The Causal Gene For Pericentral

Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2011; 52: E-Abstract 70. Free access online at:

http://www.iovs.org/ search.dtl?arvomtgsearch=true 79. Kerr NC, Smaoui N, Iannaccone A. Abnormal Cone ERGs In A Family With Congenital Nystagmus,

Photophobia, Harboring An X423L Mutation In The PAX6 Gene. Invest. Ophthalmol. Vis. Sci. 2011; 52: E-

Abstract 2399. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 80. Iyer SS, Forma G, Carboni G, Brown L, Birg A, Adamus G, Iannaccone A. Presentation Of Autoimmune

Neuro-Retinopathy (AINR) Patients With Anti-Carbonic Anhydrase II Auto-antibodies. Invest. Ophthalmol. Vis.

Sci. 2011; 52: E-Abstract 2924. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 81. Priya RR, Friedman JS, Branham KE, Brooks M, Iannaccone A, Jacobson SG, Musarella MA, Heckenlively

JR, Swaroop A. A Multi-pronged Approach For Discovery Of Genes For Inherited Retinal And Macular

Diseases: From Linkage Mapping To Exome Sequencing. Invest. Ophthalmol. Vis. Sci. 2011; 52: E-Abstract

3317. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 82. Carboni G, Forma G, Jennings BJ, Iannaccone A. Effects of Zeaxanthin (Zx) Supplementation on

Macular Pigment Optical Density (MPOD). Invest. Ophthalmol. Vis. Sci. 2011; 52: E-Abstract 3622. Free

access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 83. Forma G, Carboni G, Jennings BJ, Iannaccone A. Measures Of Macular Function After Dietary

Supplementation With Zeaxanthin (Zx). Invest. Ophthalmol. Vis. Sci. 2011; 52: E-Abstract 3637. Free access

online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 84. Birg A, Carboni G, Forma G, Adamus G, Iannaccone A. Spectral-Domain Optical Coherence

Tomography (SD-OCT) Findings in Patients with Autoimmune Neuro-Retinopathy (AINR). Invest.

Ophthalmol. Vis. Sci. 2011; 52: E-Abstract 3690. Travel Award recipient. Free access online at:

http://www.iovs.org/ search.dtl?arvomtgsearch=true 85. Iannaccone A, Neeli I, Krishnamurthy P, Lenchik N, Gerling IC, Radic MZ. Autoreactivity Against

Human Macular Tissue Antigens in Sera from Age-Related Macular Degeneration (AMD) Patients.

Invest. Ophthalmol. Vis. Sci. 2011; 52: E-Abstract 4016. Free access online at: http://www.iovs.org/

search.dtl?arvomtgsearch=true


86. Hoffman JD, Olson LM, Spencer KL, Scott WK, Agarwal A, Pericak-Vance MA, Kovach JL, Schwartz S, Iannaccone A, Haines JL. Ethnic Differences In Htra1/arms2 Association In Age-related Macular

Degeneration. Invest. Ophthalmol. Vis. Sci. 2011; 52: E-Abstract 5232. Free access online at:

http://www.iovs.org/ search.dtl?arvomtgsearch=true 87. Iannaccone A. Macular Pigment Optical Density: Findings in Aging and Age-Related Maculopathy and

Response to Supplementation (Invited speaker). Ocular Nutrition Society 2011 Educational Symposium,

Boston, October 10, 2011. 88. Cox K, Kerr NC, Kedrov M, Nishimura D, Jennings BJ, Stone EM, Sheffield VC, Iannaccone A. Phenotypic

Expression of Bardet-Biedl Syndrome in Patients Homozygous for the Common M390R Mutation in the BBS1

Gene. Pre-ARVO Retinal Ciliopathies 2012 Vision Research meeting, Ft. Lauderdale, FL, May 4-5, 2012. 89. Iannaccone A, Umfress A, Neeli I, Murphy L, Krishnamurthy P, Lenchik, N, Gerling IC, Radic MZ. Evidence

for Auto-Antibodies (auto-Abs) Recognizing Human Macular Tissue Antigens in Serum Samples of Patients

with Age-Related Macular Degeneration (AMD) Invest. Ophthalmol. Vis. Sci. 2012; 53: E-Abstract 2272. Free

access online at: http://www.iovs.org/search.dtl?arvomtgsearch=true 90. Burke T, Fishman GA, Zernant J, Schubert C, Tsang SH, Smith RT, Ayyagari R, Koenekoop RK, Umfress A,

Ciccarelli ML, Baldi A, Iannaccone A, Cremers FP, Klaver CCV, Allikmets R. Retinal phenotypes in patients

homozygous for the G1961E mutation in the ABCA4 gene. Invest. Ophthalmol. Vis. Sci. 2012; 53: E-Abstract

6442. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 91. Lenchik NI, Giorgianni G, Beranova-Giorgianni S, Gerling IC, Radic MZ, Iannaccone A. Identification of

Human Macular Tissue Antigens Recognized by Serum Auto-Antibodies (auto-Abs) in Patients with Age-

Related Macular Degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2013; 54: E-Abstract 4103. Free access

online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 92. Mills K, Radic MZ, Neeli I, Phillips ME, Cutler Peck C, Wilkes BN, Fleming JC, Iannaccone A, Kerr NC.

Protocol for Protein Isolation from Human Orbital Fat Tissue: Use for Western Blots and Antigen Biomarker

Identification in Thyroid Eye Disease. Invest. Ophthalmol. Vis. Sci. 2013; 54: E-Abstract 5903. Free access

online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 93. Jackson GR, Scott IU, Kim IK, Bressler NM, Quillen DA, Iannaccone A, Edwards JG. Evaluation of the

AdaptDx™ for detection of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2014; 55: E-

Abstract 2996. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true 94. Epstein RS, Sollenberger E, Adamus G, Iannaccone A. Clinical, functional, and imaging findings in cancer

cancer-associated retinopathy (CAR) and optic neuropathy (CAON). Invest. Ophthalmol. Vis. Sci. 2014; 55: E-Abstract 91. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true

95. Sollenberger E, Epstein RS, Adamus G, Iannaccone A. Clinical characteristics of autoimmune neuro-retinopathy (AINR). Invest. Ophthalmol. Vis. Sci. 2014; 55: E-Abstract 2509. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true

96. Ho A, Smith T, Hariri A, Chegarnov E, Ferris FL, Van Veldhuisen P, Sadda SR, Weleber RG, Birch DG, VPA Clinical Trial Group, EZ Area Working Group. Area Measurement of the Ellipsoid Zone (EZ) by SD-OCT and

its Correlation with Visual Field Identifies a Potential Anatomical Endpoint for Clinical Trials in Retinitis Pigmentosa (RP). Invest. Ophthalmol. Vis. Sci. 2014; 55: E-Abstract 3380. Free access online at: http://www.iovs.org/search.dtl? arvomtgsearch=true

97. New DD, Lenchik NI, Giorgianni F, Alhatem AH, Beranova-Giorgianni S, Gerling IC, Radic MZ, Iannaccone A.

The apoptosis inhibitor of macrophage/CD5 molecule-like protein (AIM/CD5L) is expressed in the human retina and is a target of autoreactivity in age-related macular degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2014; 55: E-Abstract 65. Travel Award recipient. Free access online at: http://www.iovs.org/

search.dtl?arvomtgsearch=true 98. Alhatem AH, Lenchik NI, Beranova-Giorgianni S, Klingeborn M, New DD, Giorgianni F, Gerling IC, Radic MZ,

Bowes Rickman C, Iannaccone A. The Apolipoprotein E4 Targeted Replacement (APOE4 TR) Mouse Model of Age-Related Macular Degeneration (AMD) Exhibits Anti-Retinal Autoreactivity. Invest. Ophthalmol. Vis. Sci. 2014; 55: E-Abstract 1173. Travel Award recipient. Free access online at: http://www.iovs.org/

search.dtl?arvomtgsearch=true 99. Iannaccone A, Alhatem AH, Lenchik NI, Giorgianni F, New DD, Beranova-Giorgianni S, Gerling IC,

Ufret-Vincenty RL, Radic MZ. Evidence for Anti-Retinal Auto-Antibodies (AAbs) in the Complement Factor H Chimeric Transgenic (Cfh-Tg) Mouse Model of Age-Related Macular Degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2014; 55: E-Abstract 1205. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true


100. Iannaccone A, New DD, Giorgianni F, Lenchik NI, Alhatem AH, Beranova-Giorgianni S, Gerling IC, Radic

MZ. Serum Auto-Antibody (AAb) Studies in Patients With AMD Identify the Apoptosis Inhibitor of

Macrophage / CD5 Molecule-Like Protein as a Novel Human Retinal Protein and an AAb Target in AMD.

PO237, American Academy of Ophthalmology meeting, Chicago, IL, Oct. 18-22, 2014. 101. Epstein RS, Sollenberger E, Adamus G, Iannaccone A. Clinical, Functional, and Imaging Characteristics of

Cancer-Associated Retinopathy and Optic Neuropathy. PO232, American Academy of Ophthalmology meeting, Chicago, IL, Oct. 18-22, 2014 (poster received highest grades for its subject area by the AAO 2014 Program Committee).

102. Iannaccone A, Sollenberger E, Epstein RS, Birg A, Adamus G. Optic Nerve/Retinal Ganglion Cell

Involvement in Autoimmune Retinopathies Resulting in Autoimmune Neuroretinopathy. PO547, American Academy of Ophthalmology meeting, Chicago, IL, Oct. 18-22, 2014.

103. Barnett JM, Kerr NC, Iannaccone A. Retinal Dysfunction and Nerve Fiber Layer Loss in Pediatric Patients

on Vigabatrin: An ERG and SD-OCT Study. AAPOS Meeting, New Orleans, LA, March 25-29, 2015 (presentation received Best Poster Award recognition, Retina section).

104. Epstein RS, New DD, Hollingsworth TJ, Meunier I, Lenchik NI, Lu Q, Gerling IC, Hamel C, Radic MZ, Iannaccone A. Defective mer-tyrosine kinase (mer-TK) function is associated with anti-arrestin and anti-

interphotoreceptor retinoid-binding protein (IRBP) autoantibodies (AAbs) in Mer, Axl, Tyro3 -/- (TAM) mice and in autosomal recessive retinitis pigmentosa (arRP) patients with a null MERTK mutation. Invest. Ophthalmol. Vis. Sci. 2015; 56: E-Abstract 169. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true

105. Iannaccone A, New DD, Giorgianni F, Lenchick NI, Beranova-Giorgianni S, Gerling IC, Radic MZ. Sera from subjects with age-related macular degeneration (AMD) exhibit strong autoreactivity against human macular Heat Shock Proteins (HSPs). Invest. Ophthalmol. Vis. Sci. 2015; 56: E-Abstract 815. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true

106. New DD, Hollingsworth TJ, Giorgianni F, Lenchik NI, Gerling IC, Beranova-Giorgianni S, Radic MZ,

Iannaccone A. The Cu/Zn+ superoxide dismutase knockout mouse (Sod1-/-), a model of age-related

macular degeneration (AMD), exhibits anti-retinal autoantibodies (AAbs) and marked signs of intraretinal inflammation prior to onset of an AMD-like phenotype. Invest. Ophthalmol. Vis. Sci. 2015; 56: E-Abstract 3986. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true (Dr. New selected to be session moderator)

107. Hollingsworth TJ, New DD, Giorgianni F, Lenchik NI, Beranova-Giorgianni S, Gerling IC, Lu Q, Wang Y, Radic MZ, Iannaccone A. Peptidylarginine deiminase (PAD4) expression and citrullination levels in normal

and mouse retinas and in murine models of late (Sod1-/-) and early-onset (Tyro3-/-, Axl-/-, Mertk-/- or TAM mice) retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2015; 56: E-Abstract 4636. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true

108. Koirala D, Iannaccone A, Radic MZ, Hollingsworth TJ, Gerling IC, Beranova-Giorgianni S, Giorgianni F. The

CD5-like (CD5L) protein is expressed by retinal pigment epithelium (RPE) cells and is a key role player in the uptake of oxidized low-density lipoproteins (oxLDL). Invest. Ophthalmol. Vis. Sci. 2016; 57: E-Abstract 5014. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true

109. Iannaccone A, Radic MZ, Beranova-Giorgianni S, Lenchik N, Hollingsworth TJ, Gerling IC, Giorgianni F.

Circulating autoantibodies in age-related macular degeneration (AMD) recognize human macular tissue antigens implicated in immunomodulation, protection from oxidative stress and apoptosis, and autophagy. Invest. Ophthalmol. Vis. Sci. 2016; 57: E-Abstract 6560. Free access online at: http://www.iovs.org/ search.dtl?arvomtgsearch=true

Other delivered presentations (abstract or proceedings not published) 1. Vingolo EM, Rispoli E, Iannaccone A, Pannarale MR. Hypothesis of immunological treatment of retinitis

pigmentosa: a pilot study with Thymopentin, preliminary results. 2nd Meeting of the Schepens International

Society, Rome, Italy, September 12-16, 1989. 2. Rispoli E, Vingolo EM, Zicari D, Iannaccone A, Napoli A, Gerlini G, Pachì A, Fallucca F. Dynamic

electroretinogram in the evolution of diabetic retinopathy in pregnancy. 2nd International Symposium on

Diabetes and Pregnancy, Fiuggi Terme, Italy, October 27-29, 1989. 3. Rispoli E, Vingolo EM, Iannaccone A. Thymopentin (Timunox) in retinitis pigmentosa: Evaluation of its

therapeutical effects after 18 months of treatment. Preliminary results. XXVI International Congress of

Ophthalmology (ICO), Singapore, March 18-24, 1990. 4. Steindl K, Forte R, Costanzi Porrini S, Iannaccone A, Piane M. Retinitis pigmentosa (RP): Genetic Program. 6º

World Congress of the International Retinitis Pigmentosa Association (IRPA), Dublin, Ireland, July 19-22, 1990.


5. Forte R, Di Iullo M, Di Marcantonio F, Ruggiero L, Steindl K, Iannaccone A, Vingolo EM, Cedrone C.

Psychological aspects of patients with retinitis pigmentosa (RP): analysis of subjective and objective

parameters. 6º World Congress of the International Retinitis Pigmentosa Association (IRPA), Dublin, Ireland,

July 19-22, 1990. 6. Steindl K, Forte R, Costanzi Porrini S, Iannaccone A. Distribution of genetic types of retinitis pigmentosa (RP):

review and personal casistic. 6º World Congress of the International Retinitis Pigmentosa Association (IRPA),

Dublin, Ireland, July 19-22, 1990. 7. Vingolo EM, Forte R, Iannaccone A, Pannarale L, Steindl K. Retinal pigmentations: a genetic-clinical

contribution to differential diagnosis. 6º World Congress of the International Retinitis Pigmentosa Association

(IRPA), Dublin, Ireland, July 19-22, 1990. 8. Iannaccone A, Vingolo EM, Forte R, Arrico L, Pannarale MR. Progressive bilateral peripapillary RPE

disturbance with perimetric and electroretinographic evidence of cone impairment. International Workshop on

Retinal Cone Dystrophies, Moorfields Eye Hospital, London, U.K., March 26-27, 1993. 9. Iannaccone A, De Propris G, Pannarale L, Amodeo S, Vingolo EM, Pannarale MR. Clinical survey of 12

cases of Laurence-Moon-Bardet-Biedl Syndrome. 4th Meeting of the Schepens International Society, Hong

Kong, March 30-April 2, 1993. 10. Forte R, Vingolo EM, Iannaccone A, Pannarale L, Pannarale MR. Clinical and electrofunctional evaluation of

a gyrate atrophy pedigree. 4th Meeting of the Schepens International Society, Hong Kong, March 30-April 2,

1993. 11. Vingolo EM, Iannaccone A, Rispoli E, Pannarale L, Amodeo S, Pannarale MR. Three-year experience in

the treatment of retinitis pigmentosa with thymopentin. 4th Meeting of the Schepens International Society,

Hong Kong, March 30-April 2, 1993. 12. Iannaccone A, Giusti C, Forte R, Zompatori L, Pannarale L, Vingolo EM. Simple microphthalmos complicated

by central retinal vein occlusion and hypertensive uveitis. 34th Meeting of the Association for Eye Research

(AER), Granada, Spain, September 15-18, 1993. 13. Grenga R, Bellelli A, Santori M, Iannaccone A, Forte R, Vingolo EM, Pannarale L. Spectroscopic analysis of

acqueous composition in retinitis pigmentosa. 34th Meeting of the Association for Eye Research (AER),

Granada, Spain, September 15-18, 1993. 14. Iannaccone A, Vingolo EM, Tanzilli P, Forte R, Pannarale L, De Propris G, Rispoli E, Pannarale MR.

Electroretinographic features of patients with the Laurence-Moon-Bardet-Biedl phenotype. [Italian] 1st

National Retinitis Pigmentosa Day, December 11, 1993. 15. Zompatori L, Iannaccone A, Forte R, Pannarale L, Vingolo EM, Pannarale MR. Ultrasonography as an aid for the

diagnosis of cilio-choroidal effusion in microphthalmic eyes. 15th Congress of the Societas Internationalis pro

Diagnostica Ultrasonica in Ophthalmologia (SIDUO), Cortina d'Ampezzo, Italy, January 22-27, 1994.

16. Zompatori L, Forte R, Iannaccone A, Pannarale L, Vingolo EM, Pannarale MR. Ultrasonographic

measurements in the diagnosis of simple microphthalmos. 15th Congress of the Societas Internationalis

pro Diagnostica Ultrasonica in Ophthalmologia (SIDUO), Cortina d'Ampezzo, Italy, January 22-27, 1994. 17. Iannaccone A, Vingolo EM, Tanzilli P, Del Beato P, Santecola R, Rispoli E. Analysis of threshold ERG

responses (STR) in Schubert-Bornschein’s congenital stationary night blindness (SB-CSNB) type 1 and

2. [Italian] 1st Meeting of the Central Italian Ophthalmological Society (SOCI), Rome, Italy, May 13, 1994. 18. Forte R, Iannaccone A, Amoroso L, Vingolo EM, Pannarale MR. Deflazacort as a treatment for cystoid macular

edema in retinitis pigmentosa. 1st Meeting of the Central Italian Ophthalmological Society (SOCI), Rome, Italy,

May 13, 1994. 19. Forte R, Iannaccone A, Gargiulo P, Pierazzi MC, Bosco D, Pantaleo A., Vingolo EM. Acetazolamide as a

treatment for macular edema in patients with diabetic retinopathy. [Italian] 15th Congress of the Italian

Society of Diabetology, Rome, Italy, May 19-21, 1994. 20. Iannaccone A, Forte R, Tanzilli P, Vingolo EM, Roncati S, Rispoli E. Electroretinographic findings in a case

of progressive bilateral atypical cone-rod-like retinopathy. ISCEV @ ARVO Western Hemisphere Meeting,

Deerfield Beach, Florida, May 13, 1995. 21. Iannaccone A. The role of electrophysiology in the diagnosis of retinal and optic nerve functional abnormalities.

Alumni and Residents Day, Coleman Building, UT Department of Ophthalmology, Memphis, May 30, 1997.

22. Johnson DA, Jablonski MM, Iannaccone A. Retinal degenerations and immune system: Update on current

laboratory investigations. Memphis Vision Interest Group Meeting, Coleman Building, UT Department of

Ophthalmology, Memphis, January 26, 1998.


23. Iannaccone A. Establishing meaningful genotype-phenotype correlations: Allelic heterogeneity in autosomal

dominant retinitis pigmentosa due to rhodopsin mutations. Memphis Vision Interest Group Meeting, UT

Department of Anatomy and Neurobiology, Link Building, November 19, 1998. 24. Iannaccone A. The ABCs of the ERG. 2nd Annual Clinical Update for the Comprehensive

Ophthalmologist, Peabody Hotel, Memphis, TN, December 12, 1998.

25. Iannaccone A. The importance of Genotype-Phenotype Correlations in Hereditary Retinal Diseases.

Molecular Biology/Molecular Genetics of the Visual System. 1999 UT Memphis Vision Research Symposium,

March 26, 1999. 26. Iannaccone A, Brewer VB, Spiegel PH, Kerr NC, Taylor JS, Pivnick EK. Visual evoked potential (VEP)

abnormalities in children with neurofibromatosis type 1 (NF1): Neuropsychological and

neuroanatomical correlates. 37th ISCEV Symposium, Eilat, Israel, April 11-16, 1999. 27. Iannaccone A. Looks like AMD, but it isn’t. Memphis Eye Society Meeting, Clarks Tower, Memphis, January

19, 2000.

28. Iannaccone A. Macular degeneration: Clinical-genetic correlates. 3rd Annual Clinical Update for the

Comprehensive Ophthalmologist, Peabody Hotel, Memphis, TN, January 22, 2000.

29. Iannaccone A. Maximal ERG response in retinitis pigmentosa due to distinct rhodopsin mutations: physio-

pathogenetic and prognostic implications. 38th ISCEV Symposium, Sydney, Australia, February 13-17, 2000. 30. Iannaccone A. Studies of retinal function in Usher syndrome. Alumni and Residents Day, Coleman Building,

University of Memphis, UT Department of Ophthalmology, Memphis, June 9, 2000.

31. Iannaccone A, Swain PK, Baldi A, Conciatori M, Ciccarelli ML, Swaroop A. Familial cone-rod dystrophy with

cystoid macular edema. Alumni and Residents Day, Coleman Building, University of Memphis, UT Department

of Ophthalmology, Memphis, June 9, 2000. 32. Parker TA, Iannaccone A. Correlation between Goldmann visual field size and maximal ERG response in

patients with Usher syndrome. Alumni and Residents Day, Coleman Building, University of Memphis, UT

Department of Ophthalmology, Memphis, June 9, 2000. 33. Lyubarsky A, Lem J, Chen J, Falsini B, Iannaccone A, Pugh EN, Jr. Functionally rodless mice: Transgenic

models for the investigation of cone function in retinal disease and therapy. Fifth Annual Vision Research

Conference, Animal Models of Retinal Degeneration: New Approaches and Applications. Ft. Lauderdale, FL,

April 27-28, 2001. 34. Iannaccone A, Yashar BM, Ciccarelli ML, Gasparri V, Baldi A, Jablonski MM, Sieving PA. Clinical and

functional findings in patients with X-linked juvenile retinoschisis associated with missense mutations in the

XLRS1 gene. XIII Biannual Meeting of the International Society for Genetic Eye Disease (ISGED), Double

Tree Ocean Front Hotel, Ft. Lauderdale, FL, May 4, 2001. 35. Iannaccone A, Ciccarelli ML, Orten DJ, Weston MD, Baldi A, Jablonski MM, Kimberling WJ. Kinetics of

visual field loss in Usher syndrome type 2. Alumni and Residents Day, Coleman Building, University of

Tennessee HSC, Department of Ophthalmology, Memphis, May 11, 2001. 36. Iannaccone A, Ciccarelli ML, Orten DJ, Weston MD, Baldi A, Jablonski MM, Kimberling WJ. Patterns of

visual function loss in Usher syndrome type 2. 39th ISCEV Symposium, Montréal-Mt. Orford, Canada, June

17-22, 2001. 37. Iannaccone A. X-linked pseudo-Usher syndrome due to mutations in the RPGR gene: A newly recognized

clinical entity. Alumni and Residents Day, Fogelman Executive Center, University of Memphis, Memphis, April

26, 2002. 38. Iannaccone A. Emerging issues in age-related macular degeneration. 6th Annual Clinical Update for the

Comprehensive Ophthalmologist, Peabody Hotel, Memphis, TN, December 7, 2002.

39. Iannaccone A. Disease Spectrum of X-linked Juvenile Retinoschisis: Clinical and Functional Findings. 32nd

Annual UTHSC Ophthalmology Alumni-Residents Day, Fogelman Executive Center, Memphis, TN, April 25, 2003.

40. Iannaccone A. Syndromic Eye Disease. 7th Annual Clinical Update for the Comprehensive Ophthalmologist,

Fogelman Executive Center, Memphis, TN, December 6, 2003.

41. Iannaccone A. Epidemiology of Age-Related Eye Disease in the Mid-South. 8th Annual Clinical Update for

the Comprehensive Ophthalmologist, Fogelman Executive Center, Memphis, TN, December 4, 2004.

42. Iannaccone A. Defining the role of inflammation in AMD. 9th Annual Clinical Update for the Comprehensive

Ophthalmologist, Freeman Auditorium, Hamilton Eye Institute, Memphis, TN, December 3, 2005.


43. Iannaccone A. Longitudinal Measurements of Visual Function in Usher Syndrome Type II. First

International Symposium on Usher Syndrome and Related Disorders, Dr. William J. Kimberling and Dr.

Claes Möller, co-organizers, Boys Town National Research Hospital, Omaha, NE, October 3-6, 2006. 44. Iannaccone A. Role of Autoimmunity in Retinal Diseases. 13th Annual Clinical Update for the Comprehensive

Ophthalmologist, Freeman Auditorium, Hamilton Eye Institute, Memphis, TN, December 5, 2009.

45. Iannaccone A. Update on Treatment Options for Patients with Retinal Degenerative Diseases. 14th Annual

Clinical Update for the Comprehensive Ophthalmologist, Freeman Auditorium, Hamilton Eye Institute,

Memphis, TN, December 11, 2010. 46. Iannaccone A. The Era of Molecular Ophthalmology: Why Getting Your Patient Genotyped Matters. 15th

Annual Clinical Update for the Comprehensive Ophthalmologist, Freeman Auditorium, Hamilton Eye Institute,

Memphis, TN, December 10, 2011. 47. Iannaccone A. The Era of Molecular Ophthalmology: Update on the Valproic Acid Clinical Trial for

Dominant Retinitis Pigmentosa. 16th Annual Clinical Update for the Comprehensive Ophthalmologist,

Freeman Auditorium, Hamilton Eye Institute, Memphis, TN, December 8, 2012. 48. Iannaccone A. The new Center for Retinal Degenerations and Ophthalmic Genetic Diseases at Duke:

Changing the landscape of hereditary blindness. Duke Eye Center Advisory Board Meeting, Hudson

4510A/B Auditorium, Durham, NC, Oct. 28, 2016

professor of ophthalmology director, center for retinal ... · professor of ophthalmology director,...

Documents